Publikationen

ID: 523087

Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.

Acta Haematol 2022; 145(4): 454-457; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Case Reports;

 Höpting M, Budde U, Tiede A, Grube M, Hahn J, Herr W, Heimerl S, Hart C Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 519057

Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.

Am J Hematol 2022; 97(8): 1023-1034; Impact Factor=12.8; Impact Factor 2022=12.8; Typ=Journal Article;Randomized Controlled Trial;Research Support, Non-U.S. Gov't;

Beelen DW, Stelljes M, Reményi P, Wagner-Drouet EM, Dreger P, Bethge W, Ciceri F, Stölzel F, Junghanß C, Labussiere-Wallet H, Schaefer-Eckart K, Grigoleit GU, Scheid C, Patriarca F, Rambaldi A, Niederwieser D, Hilgendorf I, Russo D, Socié G, Holler E, Glass B, Casper J, Wulf G, Basara N, Bieniaszewska M, Stuhler G, Verbeek M, La Rocca U, Finke J, Benedetti F, Pichlmeier U, Klein A, Baumgart J, Markiewicz M

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 519331

BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours Ann Oncol 2022; 33 Suppl 7(7): S1404-S1405; Impact Factor=50.5; Impact Factor 2022=50.5; Typ=Meeting Abstract;

Mackensen A, Haanen JBAG, Koenecke C, Alsdorf W, Wagner-Drouet E, Heudobler D, Borchmann P, Bokemeyer C, Klobuch S, Smit E, Mueller F, Desuki A, Lueke F, Wiegert E, Flemmig C, Schulz-Eying C, Rengstl B, Preussner L, Tuereci O, Sahin U

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 506559

Tachycardiomyopathy entails a dysfunctional pattern of interrelated mitochondrial functions.

Basic Res Cardiol 2022; 117(1): ; Impact Factor=9.5; Impact Factor 2022=9.5; Typ=Journal Article; Paulus MG, Renner K, Nickel AG, Brochhausen C, Limm K, Zügner E, Baier MJ, Pabel S, Wallner S, Birner C, Luchner A, Magnes C, Oefner PJ, Stark KJ, Wagner S, Maack C, Maier LS, Streckfuss- Bömeke K, Sossalla S, Dietl A

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 515266

Immunometabolic Markers in a Small Patient Cohort Undergoing Immunotherapy.

Biomolecules 2022; 12(5): ; Impact Factor=5.5; Impact Factor 2022=5.5; Typ=Journal Article;Research Support, Non-U.S. Gov't;

 Hofbauer J, Hauck A, Matos C, Babl N, Decking SM, Rechenmacher M, Schulz C, Regotta S, Mickler M, Haferkamp S, Siska PJ, Herr W, Renner K, Kreutz M, Schnell A

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528377

Cohesin-STAG2 Mutations Alter Chromatin Structure and Gene Regulation in Human Acute Myeloid Leukemia

Blood 2022; 140 Suppl 1(): 3379-3380; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

 Fischer A, Mulet-Lazaro R, Nuetzel M, van Herk S, Stanewsky H, Ackermann U, Reuschel E, Strieder N, Hernandez-Lopez I, Herr W, Valk PJM, Rehli M, Delwel R, Gebhard C

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528350

Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy

Blood 2022; 140 Suppl 1(): 1867-1869; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

Capellini A, Etra A, Alousi AM, Al Malki MM, Choe H, Defilipp Z, Hogan WJ, Kitko CL, Ayuk FA, Baez J, Gandhi I, Kasikis S, Gleich S, Hexner EO, Hoepting M, Kapoor U, Kowalyk S, Kwon D, Langston A, Mielcarek M, Morales G, Ozbek U, Qayed M, Reshef R, Roesler W, Spyrou N, Young R, Chen YB, Ferrara JLM, Levine JE

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528372

Effects of Bacterial Metabolites on CAR-T Cell Therapy

Blood 2022; 140 Suppl 1(): 12703-12703; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

 Becker L, Perl M, Knoedler L, Herr W, Poeck H

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 526643

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

Blood 2022; 140 Suppl 2(): 10-13; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

Illerhaus G, Farreri AJM, Binder M, Borchmann P, Hasenkamp J, Stilgenbauer S, Roeth A, Webern T, Egerer G, Ernst T, Hertenstein B, Lenz G, Kobbe G, Brunnberg U, Schmidt C, Kneba M, Dreyling M, Moehle R, Panse J, Heinicke T, Schroll S, Larsen TS, Salwender H, Naumann R, Hess G, Thurner L,

 Pukrop T, Keller U, Blystadt AK, Kroschinsky FP, Re F, Pulczynski E, Orsucci L, Pospiech L, Deckert M, Ponzoni M, Wendler J, Valk E, Calimeri T, Kasenda B, Trepel M, Fricker H, von Gottberg P, Burger E, Ihorst G, Grishina O, Hader C, Zucca E, Finke J, Schorb E

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 527478

Expansion of Plasmablasts at Day 90 after Allogeneic Stem Cell Transplantation Predict Chronic Gvhd Blood 2022; 140 Suppl 1(): 4776-4777; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

Habenicht KM, Bootz A, Schaefer S, Vasova I, Fante M, Schneider A, Rehli M, Hoffmann P, Roesler W,

 Edinger M, Herr W, Mackensen A, Wolff D, Winkler J, Winkler TH Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 508659

GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.

Blood 2022; 140(4): 349-358; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Journal Article;

 

Bethge WA, Martus P, Schmitt M, Holtick U, Subklewe M, von Tresckow B, Ayuk F, Wagner-Drouet EM, Wulf GG, Marks R, Penack O, Schnetzke U, Koenecke C, von Bonin M, Stelljes M, Glass B, Baldus CD, Vucinic V, Mougiakakos D, Topp M, Fante MA, Schroers R, Bayir L, Borchmann P, Buecklein V, Hasenkamp J, Hanoun C, Thomas S, Beelen DW, Lengerke C, Kroeger N, Dreger P

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528359

Harnessing the Expression of TNFR2 on Tregs to Prevent Agvhd

Blood 2022; 140 Suppl 1(): 4465-4466; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

Vargas JG, Kanzler C, Scheller L, Kreckel J, Shaikh H, Lang I, Medler J, Anany M, Steinfatt T, Hartweg J, Haack S, Holler E, Buettner-Herold M, Gaviria PT, Wajant H, Beilhack A, Einsele H

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528358

IFN-Gamma Is Crucial for the Counterbalance of T Cell-Mediated Injury to the Intestinal Stem Cell Compartment By Regulatory T Cells in Mice and Humans

Blood 2022; 140 Suppl 1(): 10223-10224; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

 Goettert S, Fischer JC, Eisenkolb G, Orberg ET, Jarosch S, Holler E, Busch D, Heidegger S, Poeck H Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528348

Identification of Bacterial and Viral Consortia for the Production of Intestinal Microbiota-Derived Metabolites Associated with Protection in Allogeneic Stem Cell Transplantation Patients

Blood 2022; 140 Suppl 1(): 7619-7621; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

Orberg ET, Meedt E, Hiergeist A, Xue JL, Heinrich P, Ghimire S, Tiefgraber M, Goeldel S, Eismann T, Schwarz A, Jarosch S, Steiger K, Kleigrewe K, Fischer JC, Janssen KP, Quante M, Heidegger S, Herhaus P, Verbeek M, Ruland J, Schulz C, Weber D, Edinger M, Wolff D, Busch D, Herr W, Bassermann F, Deng L, Gessner A, Holler E, Poeck H

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528347

Immunomodulatory Microbial Metabolites Identified in Allo-SCT Patients Protect from GvHD By Sting Dependent Modulation of Intestinal Tissue Homeostasis

Blood 2022; 140 Suppl 1(): 7336-7337; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

 Goettert S, Thiele-Orberg E, Fan KJ, Ghimire S, Heinrich P, Herr W, Heidegger S, Holler E, Poeck H Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528357

Inhibition of the Receptor Interactive Protein Kinase 1 (RIP1) Pathway Prevents Acute Gvhd

Blood 2022; 140 Suppl 1(): 7330-7331; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

Ferrara JLM, Acosta MP, Jeong S, Levine JE, Holler E, Webster J, Morales G, Vucic D Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528381

Itacitinib and Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease: Phase 1/2 Results from Gravitas-309

Blood 2022; 140 Suppl 1(): 1870-1871; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting

 

Abstract;

Im A, Wolff D, Cutler C, Zeiser R, Shah NN, Tan MT, Sanz J, Ali H, Milone G, LaW AD, Russo D, Wagner EM, Ivanova O, Hou K, Bleam M, Morariu-Zamfir R, Pavletic SZ

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528451

Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma

Blood 2022; 140 Suppl 1(): ; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract; Straka C, Schaefer-Eckart K, Hertenstein B, Bassermann F, Salwender H, Langer C, Kroenke J, Kull M, Schilling G, Schieferdecker A, Engelhardt M, Knop S, Reusch J, Roesler W, Metzner B, Hebart H,

 Reichle A, Grube M, Frickhofen N, Gerecke C, Fuhrmann S, Jung W, Gramatzki M, Decker T, Dechow T, Greiner J, Bruemmendorf TH, Ababei J, von Metzler I, Naumann R, Fritz E, Hentrich M, Bojko P, Kubin T, Schmidt C, Kaufmann M, Schmidt B, Hinke A, Einsele H

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 527491

Outcome of 841 Older Patients (> 55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols

Blood 2022; 140 Suppl 1(): ; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract; Goekbuget N, Viardot A, Steffen B, Hahn J, Spriewald B, Martin S, Raffel S, Teichmann LL, Trummer A, Alsdorf W, Morgner A, Schwartz S, Stelljes M, Vucinic V, Alakel N, Stoltefuss A, Baldus CD, Brueggemann M, Serve H, Hoelzer D

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528373

Overcoming CAR-T Cell Exhaustion and Improving Antitumoral Efficacy in Hematologic Neoplasms Utilizing CRISPR/ Cas9 Technology

Blood 2022; 140 Suppl 1(): 12701-12702; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

 Knoedler L, Perl M, Becker L, Poeck H, Schmidl C, Herr W Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 527479

Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid- Refractory Chronic Graft Versus Host Disease

Blood 2022; 140 Suppl 1(): ; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract; Soares MV, Gomez VE, Azevedo RI, Pereira PNG, Velazquez TC, Garcia-Calderon CB, Tharmaratnam K, Cabral IA, Ribeiro AC, Mendes L, Juncal C, Roncon S, Pais AT, Alho AC, Gil AR, Espada EL, Rodrigues A, Garcao A, Yaspo ML, Warnatz HJ, Lehrach H, Barbosa-Morais NL, Quintas AM, Palmela P, Caldas C, Ferreira R, Leite L, Martins C, Lourenco F, Moreno R, Raposo J, Campilho F, Cheyne CP, Garcia-Finana M, Campos A, Baron F, Arpinati M, Edinger M, Ritz J, Vaz CP, Perez-Simon JA, Lacerda JF

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528382

Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation: Results from the German Stem Cell Transplant Registry (DRST)

Blood 2022; 140 Suppl 1(): 10563-10565; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract;

 

Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, Middeke JM, Kroeger N, Ayuk FA, Eder M, Bethge W, Finke J, Bertz H, Kobbe G, Kaufmann M, Platzbecker U, Beverungen D, Schmid C, von Bonin M, Egger-Heidrich K, Heberling L, Trautmann-Grill K, Teipel R, Bug G, Tischer J, Fraccaroli A, Holler B, Wolff D, Luft T, Roesler W, Schaefer-Eckart K, Dressler S, Scheid C, Holtick U, Klein S, Blau IW, Burchert A, Wulf G, Hasenkamp J, Schwerdtfeger R, Kaun S, Wittke C, Wortmann F, Neidlinger H, Bornhaeuser M, Schetelig J, German Cooperative Transplant Stud

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528375

Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 281 T-ALL/T-Lbl Patients: Excellent Outcome of Standard Risk Thymic T-ALL

Blood 2022; 140 Suppl 1(): ; Impact Factor=20.3; Impact Factor 2022=20.3; Typ=Meeting Abstract; Goekbuget N, Fiedler W, Alakel N, Topp MS, Hanoun M, Steffen B, Waesch R, Viardot A, Nachtkamp K, Stelljes M, Poeck H, Vucinic V, Boell B, Beck J, Fransecky L, Wendelin K, Schneller F, Faul C, Buecklein VL, Reiser L, Brueggemann M, Serve H, Schwartz S

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 505341

Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood Adv 2022; 6(12): 3707-3715; Impact Factor=7.5; Impact Factor 2022=7.5; Typ=Journal Article; Etra A, Gergoudis S, Morales G, Spyrou N, Shah J, Kowalyk S, Ayuk F, Baez J, Chanswangphuwana C, Chen YB, Choe H, DeFilipp Z, Gandhi I, Hexner E, Hogan WJ, Holler E, Kapoor U, Kitko CL, Kraus S, Lin JY, Al Malki M, Merli P, Pawarode A, Pulsipher MA, Qayed M, Reshef R, Rösler W, Schechter T, Van Hyfte G, Weber D, Wölfl M, Young R, Özbek U, Ferrara JLM, Levine JE

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523177

GVHD and GFRS in patients with AML undergoing allogeneic transplantation with treosulfan- versus busulfan-based conditioning: a subgroup analysis of the randomized phase III MC-FludT.14/L trial Bone Marrow Transplant 2022; 57 Suppl 1(SUPPL 1): 35-36; Impact Factor=4.8; Impact Factor

2022=4.8; Typ=Meeting Abstract;

Stoelzel F, Stelljes M, Beelen D, Markiewicz M, Remenyi P, Dreger P, Ciceri F, Wagner-Drouet EM, Junghanss C, Scheid C, Patriarca F, Socie G, Hilgendorf I, Rambaldi A, Schaefer-Eckart K, Russo D, Grigoleit GU, Wulf G, Basara N, Glass B, Labussiere-Wallet H, Stuhler G, Bieniaszewska M, Casper J,

 Holler E, Benedetti F, Iori AP, Trenschel R, Bethge W Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523184

Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.

Bone Marrow Transplant 2022; 57(7): 1150-1163; Impact Factor=4.8; Impact Factor 2022=4.8; Typ=Journal Article;Systematic Review;Research Support, N.I.H., Extramural;Research Support, Non-

U.S. Gov't;

Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H,

 

Tichelli A

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 511818

Patient-tailored adoptive immunotherapy with ebv-specific t cells from related and unrelated donors

Bone Marrow Transplant 2022; 57 Suppl 1(SUPPL 1): 153-154; Impact Factor=4.8; Impact Factor

2022=4.8; Typ=Meeting Abstract;

Bonifacius A, Tischer-Zimmermann S, Lamottke B, Schultze-Florey R, Goudeva L, Heuft HG, Arseniev L, Beier R, Beutel G, Cario G, Froehlich B, Greil J, Hansmann L, Hasenkamp J, Hoefs M, Hundsdoerfer P, Jost E, Kafa K, Kroeger N, Mathas S, Meisel R, Nathrath M, Putkonen M, Ravens S, Sala E, Sauer M, Schroers R, Steckel NK, Trappe RU, Verbeek M, Wagner-Drouet EM, Wolff D, Blasczyk R, Eiz-Vesper B, Maecker-Kolhoff B

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523183

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network.

Bone Marrow Transplant 2022; 57(9): 1458-1460; Impact Factor=4.8; Impact Factor 2022=4.8; Typ=Letter;Research Support, Non-U.S. Gov't;

Perovic V, Sabol I, Grce M, Inngjerdingen M, Pulanic D, Peric Z, Peczynski C, Polge E, Koenecke C, Dickinson A, Greinix H, Basak G, Penack O, Scherwath A, Barata A, Olivieri A, Lawitschka A, Mensah- Glanowska P, Andrikovics H, Schoemans H, Wolff D

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523077

Prospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease from multiple transplant centers

Bone Marrow Transplant 2022; 57 Suppl 1(SUPPL 1): 207-208; Impact Factor=4.8; Impact Factor

2022=4.8; Typ=Meeting Abstract;

Langer R, Lelas A, Desnica L, Rittenschober M, Piekarska A, Sadowska-Klasa A, Sabol I, Greinix H, Dickinson A, Inngjerdingen M, Lawitschka A, Vrhovac R, Pulanic D, Klein S, Middeke JM, Grube M,

 Holler E, Edinger M, Herr W, Wolff D

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 510793

t-haplo for SCD: A phase ii trial to assess haploidentical ab t-depleted stem cell transplantation in patients with scd with no available msd, un update

Bone Marrow Transplant 2022; 57 Suppl 1(SUPPL 1): 248-249; Impact Factor=4.8; Impact Factor

2022=4.8; Typ=Meeting Abstract;

Foell J, Kleinschmidt K, Troeger A, Ellinger S, Spachtholz R, Kramer S, Jakob M, Hanafee T, Offner R, Brosig AM, Schmidt R, Eyrich M, Wolff D, Corbacioglu S

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 527490

Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers. Cancers (Basel) 2022; 14(20): ; Impact Factor=5.2; Impact Factor 2022=5.2; Typ=Journal Article;Review;

Ettl T, Grube M, Schulz D, Bauer RJ

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 508524

Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-

 

Specific CAR-T Cells.

Cancers (Basel) 2022; 14(20): ; Impact Factor=5.2; Impact Factor 2022=5.2; Typ=Journal Article;

 Harrer DC, Schenkel C, Berking C, Herr W, Abken H, Dörrie J, Schaft N Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523197

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome.

Cancers (Basel) 2022; 14(9): ; Impact Factor=5.2; Impact Factor 2022=5.2; Typ=Journal Article; Menck K, Wlochowitz D, Wachter A, Conradi LC, Wolff A, Scheel AH, Korf U, Wiemann S, Schildhaus HU, Bohnenberger H, Wingender E, Pukrop T, Homayounfar K, Beißbarth T, Bleckmann A

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 512814

Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA Consortium.

Cancers (Basel) 2022; 14(20): ; Impact Factor=5.2; Impact Factor 2022=5.2; Typ=Journal Article;

 Lüke F, Haller F, Utpatel K, Krebs M, Meidenbauer N, Scheiter A, Spoerl S, Heudobler D, Sparrer D,

 Kaiser U, Keil F, Schubart C, Tögel L, Einhell S, Dietmaier W, Huss R, Dintner S, Sommer S, Jordan F, Goebeler ME, Metz M, Haake D, Scheytt M, Gerhard-Hartmann E, Maurus K, Brändlein S, Rosenwald A, Hartmann A, Märkl B, Einsele H, Mackensen A, Herr W, Kunzmann V, Bargou R, Beckmann MW,

 Pukrop T, Trepel M, Evert M, Claus R, Kerscher A

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523076

CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop.

Cells 2022; 11(23): ; Impact Factor=6.0; Impact Factor 2022=6.0; Typ=Journal Article;

 Harrer DC, Schenkel C, Bezler V, Kaljanac M, Hartley J, Barden M, Pan H, Holzinger A, Herr W, Abken H

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 519055

Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis.

Clin Cancer Res 2022; 28(19): 4258-4266; Impact Factor=11.5; Impact Factor 2022=11.5; Typ=Editorial; Nagler A, Ngoya M, Galimard JE, Labopin M, Bornhäuser M, Stelljes M, Finke J, Ganser A, Einsele H, Kröger N, Brecht A, Bethge W, Edinger M, Kulagin A, Passweg J, Blau IW, Elmaagacli A, Schäfer-Eckart K, Platzbecker U, Schroeder T, Bunjes D, Tischer J, Martin S, Spyridonidis A, Giebel S, Savani B, Mohty M

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 515606

Second Cancer After Additive Chemotherapy in Patients With Colon Cancer.

Clin Colorectal Cancer 2022; 21(4): 354-361; Impact Factor=3.4; Impact Factor 2022=3.4; Typ=Journal Article;

Teufel A, Li M, Gerken M, Ebert MP, Schlitt HJ, Evert M, Herr W, Klinkhammer-Schalke M Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 529295

Wireless handheld focused ultrasound in student teaching during the COVID-19 pandemic: Initial results of a pilot study1.

 

Clin Hemorheol Microcirc 2022; (): ; Impact Factor=2.1; Impact Factor 2022=2.1; Typ=Journal Article;

 Kaiser U, Dropco I, Reuthner K, Ertl M, Schlitt HJ, Herr W, Stroszczynski C, Jung EM Medline-ID vorhanden, Web of Science-ID (ISI-LOC) fehlt

 

ID: 520925

Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.

Clin Infect Dis 2022; 75(1): 185-185; Impact Factor=11.8; Impact Factor 2022=11.8; Typ=Published Erratum;

de Castilhos J, Zamir E, Hippchen T, Rohrbach R, Schmidt S, Hengler S, Schumacher H, Neubauer M,

 Kunz S, Müller-Esch T, Hiergeist A, Gessner A, Khalid D, Gaiser R, Cullin N, Papagiannarou SM, Beuthien-Baumann B, Krämer A, Bartenschlager R, Jäger D, Müller M, Herth F, Duerschmied D, Schneider J, Schmid RM, Eberhardt JF, Khodamoradi Y, Vehreschild MJGT, Teufel A, Ebert MP, Hau P, Salzberger B, Schnitzler P,  Poeck H, Elinav E, Merle U, Stein-Thoeringer CK

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 500323

Prolonged Suppression of Butyrate-Producing Bacteria Is Associated With Acute Gastrointestinal Graft- vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell Transplantation.

Clin Infect Dis 2022; 74(4): 614-621; Impact Factor=11.8; Impact Factor 2022=11.8; Typ=Journal Article;Research Support, Non-U.S. Gov't;

 Meedt E, Hiergeist A, Gessner A, Dettmer K, Liebisch G, Ghimire S, Poeck H, Edinger M, Wolff D,

 Herr W, Holler E, Weber D

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 493707

Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.

Clin Infect Dis 2022; 75(1): e1063-e1071; Impact Factor=11.8; Impact Factor 2022=11.8; Typ=Journal Article;

de Castilhos J, Zamir E, Hippchen T, Rohrbach R, Schmidt S, Hengler S, Schumacher H, Neubauer M,

 Kunz S, Müller-Esch T, Hiergeist A, Gessner A, Khalid D, Gaiser R, Cullin N, Papagiannarou SM, Beuthien-Baumann B, Krämer A, Bartenschlager R, Jäger D, Müller M, Herth F, Duerschmied D, Schneider J, Schmid RM, Eberhardt JF, Khodamoradi Y, Vehreschild MJGT, Teufel A, Ebert MP, Hau P, Salzberger B, Schnitzler P,  Poeck H, Elinav E, Merle U, Stein-Thoeringer CK

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 485421

Correction to: The impact of epicardial adipose tissue in patients with acute myocardial infarction.

Clin Res Cardiol 2022; 111(3): ; Impact Factor=5.0; Impact Factor 2022=5.0; Typ=

Fisser C, Colling S, Debl K, Hetzenecker A, Sterz U, Hamer OW, Fellner C, Maier LS, Buchner S, Arzt M Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523551

Covid19 vaccination-associated portal vein thrombosis-An interdisciplinary clinical challenge.

Clin Res Hepatol Gastroenterol 2022; 46(8): ; Impact Factor=2.7; Impact Factor 2022=2.7; Typ=Case Reports;

Bogovic N, Doenecke A, Hart C, Lürken L, Heimerl S, Eissnert C, Schlitt HJ, Bitterer F Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528778

Unusually swift response of relapsed Burkitt leukemia to R-DHAP.

 

EJHaem 2022; 3(3): 1003-1008; Impact Factor=n.a.; Impact Factor 2022=n.a.; Typ=Case Reports;

 Harrer DC, Denk A, Keil F, Menhart K, Mayer S, Wolff D, Edinger M, Herr W, Grube M Medline-ID vorhanden, Web of Science-ID (ISI-LOC) fehlt

 

ID: 523196

Sedentary behavior and cancer-an umbrella review and meta-analysis.

Eur J Epidemiol 2022; 37(5): 447-460; Impact Factor=13.6; Impact Factor 2022=13.6; Typ=Journal Article;Meta-Analysis;Review;

Hermelink R, Leitzmann MF, Markozannes G, Tsilidis K, Pukrop T, Berger F, Baurecht H, Jochem C Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523182

Dysregulation of the B lymphocyte compartment in patients with chronic graft-versus-host disease

Eur J Immunol 2022; 52 Suppl 1(): 311-311; Impact Factor=5.4; Impact Factor 2022=5.4; Typ=Meeting Abstract;

Habenicht K, Bootz A, Schneider A, Schaefer S, Hoffmann P, Winkler J, Wolff D, Winkler T Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523218

Increased CD47 expression antagonizes phagocytosis of alloreactive donor T cells after allo-HSCT

Eur J Immunol 2022; 52 Suppl 1(): 410-410; Impact Factor=5.4; Impact Factor 2022=5.4; Typ=Meeting Abstract;

Flamann C, Matos C, Kreutz M, Shaikh H, Beilhack A, Buettner-Herold M, Lischer C, Voelkl S, Zeun J, Kremer A, Bitterer K, Kellner C, Saul D, Mougiakakos D, Mackensen A, Bruns H

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528454

A Proteomic Platform Enables to Test for AML Normalization In Vitro.

Front Chem 2022; 10(): ; Impact Factor=5.5; Impact Factor 2022=5.5; Typ=Journal Article;

Meier-Menches SM, Neuditschko B, Janker L, Gerner MC, Schmetterer KG, Reichle A, Gerner C Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 506556

Acidic Microenvironments Found in Cutaneous Leishmania Lesions Curtail NO-Dependent Antiparasitic Macrophage Activity.

Front Immunol 2022; 13(): ; Impact Factor=7.3; Impact Factor 2022=7.3; Typ=Journal Article;

Frick L, Hinterland L, Renner K, Vogl M, Babl N, Heckscher S, Weigert A, Weiß S, Gläsner J, Berger R, Oefner PJ, Dettmer K, Kreutz M, Schatz V, Jantsch J

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 487097

Anti-Thymocyte Globulin Treatment Augments 1,25-Dihydroxyvitamin D3 Serum Levels in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Front Immunol 2022; 12(): ; Impact Factor=7.3; Impact Factor 2022=7.3; Typ=Journal Article;

 Matos C, Peter K, Weich L, Peuker A, Schoenhammer G, Roider T, Ghimire S, Babl N, Decking S, Güllstorf M, Kröger N, Hammon K, Herr W, Stark K, Heid IM, Renner K, Holler E, Kreutz M

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523180

Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?

Front Immunol 2022; 13(): ; Impact Factor=7.3; Impact Factor 2022=7.3; Typ=Journal Article;Research Support, Non-U.S. Gov't;

 

Krausz M, Mitsuiki N, Falcone V, Komp J, Posadas-Cantera S, Lorenz HM, Litzman J, Wolff D, Kanariou M, Heinkele A, Speckmann C, Häcker G, Hengel H, Gámez-Díaz L, Grimbacher B

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523078

Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation.

Front Immunol 2022; 13(): ; Impact Factor=7.3; Impact Factor 2022=7.3; Typ=Journal Article;Research Support, Non-U.S. Gov't;

 Matos C, Mamilos A, Shah PN, Meedt E, Weber D, Ghimire S, Hiergeist A, Gessner A, Dickinson A, Dressel R, Walter L, Stark K, Heid IM, Poeck H, Edinger M, Wolff D, Herr W, Holler E, Kreutz M,

 Ghimire S

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 518644

Low Intestinal IL22 Associates With Increased Transplant-Related Mortality After Allogeneic Stem Cell Transplantation.

Front Immunol 2022; 13(): ; Impact Factor=7.3; Impact Factor 2022=7.3; Typ=Journal Article;Research Support, Non-U.S. Gov't;

 Ghimire S, Ederer KU, Meedt E, Weber D, Matos C, Hiergeist A, Zeman F, Wolff D, Edinger M, Poeck

 H, Herr W, Gessner A, Holler E, Bülow S

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523084

All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma.

Front Oncol 2022; 12(): ; Impact Factor=4.7; Impact Factor 2022=4.7; Typ=Journal Article;

 Fante MA, Felsenstein M, Mayer S, Gerken M, Klinkhammer-Schalke M, Herr W, Vogelhuber M,

 Reichle A, Heudobler D

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 505318

Breakouts-A Radiological Sign of Poor Prognosis in Patients With Brain Metastases.

Front Oncol 2022; 12(): ; Impact Factor=4.7; Impact Factor 2022=4.7; Typ=Journal Article;

 Blazquez R, Proescholdt MA, Klauser M, Schebesch KM, Doenitz C, Heudobler D, Stange L, Riemenschneider MJ, Bumes E, Rosengarth K, Schicho A, Schmidt NO, Brawanski A, Pukrop T, Wendl C

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528779

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature.

Front Oncol 2022; 12(): ; Impact Factor=4.7; Impact Factor 2022=4.7; Typ=Case Reports;

 Harrer DC, Lüke F, Einspieler I, Menhart K, Hellwig D, Utpatel K, Herr W, Reichle A, Heudobler D Medline-ID vorhanden, Web of Science-ID (ISI-LOC) fehlt

 

ID: 523195

Drug Repurposing by Tumor Tissue Editing.

Front Oncol 2022; 12(): ; Impact Factor=4.7; Impact Factor 2022=4.7; Typ=Journal Article;Review;

 Lüke F, Harrer DC, Pantziarka P, Pukrop T, Ghibelli L, Gerner C, Reichle A, Heudobler D Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528349

Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity.

Front Oncol 2022; 12(): ; Impact Factor=4.7; Impact Factor 2022=4.7; Typ=Editorial;

 Heudobler D, Ghibelli L, Reichle A

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528379

Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma.

Front Oncol 2022; 12(): ; Impact Factor=4.7; Impact Factor 2022=4.7; Typ=Journal Article;Review; Lindner AK, Tulchiner G, Seeber A, Siska PJ, Thurnher M, Pichler R

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 527482

Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin.

Haematologica 2022; 107(9): 2064-2071; Impact Factor=10.1; Impact Factor 2022=10.1; Typ=Journal Article;Research Support, Non-U.S. Gov't;

Kayser S, Sartor C, Luskin MR, Webster J, Giglio F, Panitz N, Brunner AM, Fante M, Lutz C, Wolff D, Ho AD, Levis MJ, Schlenk RF, Papayannidis C

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 517298

Management of Antithrombin Deficiency in Pregnancy.

Hamostaseologie 2022; 42(5): 320-329; Impact Factor=3.2; Impact Factor 2022=3.2; Typ=Journal Article;

 Hart C, Rott H, Heimerl S, Linnemann B

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 517297

Venous Thromboembolism Issues in Women.

Hamostaseologie 2022; 42(5): 290-299; Impact Factor=3.2; Impact Factor 2022=3.2; Typ=Review;Journal Article;

Linnemann B, Rott H, Zotz R, Hart C

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 517296

Women's Health Issues in Thrombosis and Haemostasis.

Hamostaseologie 2022; 42(5): 285-286; Impact Factor=3.2; Impact Factor 2022=3.2; Typ=Journal Article;

Linnemann B, Hart C, Speakers of the GTH Working Group "Women's Health" Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 522489

Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.

Hemasphere 2022; 6(2): ; Impact Factor=6.6; Impact Factor 2022=6.6; Typ=Journal Article;

Houot R, Poeschel V, Altmann B, Angel S, Thurner L, Illmer T, Andre M, Dreyling M, Maisonneuve H, Tilly H, Mayer S, Casasnovas O, Le Gouill S, Offner F, Cartron G, Kerkhoff A, Weber T, Hoffmann J, Ziepert M, Klapper W, Itti E, Hellwig D, Natchkebia G, de Leval L, Rosenwald A, Haioun C, Dercle L, Gaulard P, Held G

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 519341

BNT211: A PHASE I TRIAL EVALUATING SAFETY AND EFFICACY OF CLDN6 CAR-T CELLS AND CARVAC-MEDIATED IN VIVO EXPANSION IN PATIENTS WITH CLDN6-POSITIVE ADVANCED SOLID TUMORS

Hum Gene Ther 2022; 33(7-8): A2-A2; Impact Factor=4.2; Impact Factor 2022=4.2; Typ=Meeting Abstract;

Alsdorf W, Mackensen A, Haanen J, Koenecke C, Wagner-Drouet E, Heudobler D, Borchmann P, Bokemeyer C, Klobuch S, Smit E, Desuki A, Lueke F, Wiegert E, Schulz C, Rengstl B, Preussner L, Tuereci O, Sahin U

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 470436

Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype.

Int J Cancer 2022; 150(4): 617-625; Impact Factor=6.4; Impact Factor 2022=6.4; Typ=Journal Article;

 Gebhard C, Mulet-Lazaro R, Glatz D, Schwarzfischer-Pfeilschifter L, Schirmacher P, Gaedcke J, Weichert W, Reuschel E, Dietmaier W, Rehli M

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528453

Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer.

Int J Mol Sci 2022; 23(3): ; Impact Factor=5.6; Impact Factor 2022=5.6; Typ=Journal Article; Corsi F, Capradossi F, Pelliccia A, Briganti S, Bruni E, Traversa E, Torino F, Reichle A, Ghibelli L Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 506314

LDHB Overexpression Can Partially Overcome T Cell Inhibition by Lactic Acid.

Int J Mol Sci 2022; 23(11): ; Impact Factor=5.6; Impact Factor 2022=5.6; Typ=Journal Article;

 Decking SM, Bruss C, Babl N, Bittner S, Klobuch S, Thomas S, Feuerer M, Hoffmann P, Dettmer K, Oefner PJ, Renner K, Kreutz M

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 515582

Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin.

Int J Mol Sci 2022; 23(19): ; Impact Factor=5.6; Impact Factor 2022=5.6; Typ=Journal Article; Seliger C, Meyer AL, Leidgens V, Rauer L, Moeckel S, Jachnik B, Proske J, Dettmer K, Rothhammer-

Hampl T, Kaulen LD, Riemenschneider MJ, Oefner PJ, Kreutz M, Schmidt NO, Merrill M, Uhl M, Renner

 K, Vollmann-Zwerenz A, Proescholdt M, Hau P

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523085

Longitudinal Multi-omic Analysis in Allogeneic Stem Cell Transplantation Patients identify Intestinal Microbiome and Metabolomic Signatures for Acute Graft-vs-Host-Disease

Internist (Berl) 2022; 63 Suppl 3(SUPPL 3): 338-338; Impact Factor=n.a.; Impact Factor 2022=n.a.; Typ=Meeting Abstract;

Orberg ET, Meedt E, Hiergeist A, Xue JL, Herhaus P, Verbeek M, Bassermann F, Eismann T, Pianka A, Goeldel S, Ghimire S, Herr W, Weber D, Edinger M, Wolff D, Deng L, Gessner A, Holler E, Poeck H Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 483913

Therapeutic options for CTLA-4 insufficiency.

J Allergy Clin Immunol 2022; 149(2): 736-746; Impact Factor=14.2; Impact Factor 2022=14.2; Typ=Journal Article;

Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králíčková P,  de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD, Grimbacher B Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 430341

Oral and Subcutaneous Anticancer Therapy Training Course for Non-physician Healthcare Professionals: a Survey Evaluating the Relevance of its Content and its Implications in the Practice of Cancer Care.

J Cancer Educ 2022; 37(1): 120-127; Impact Factor=1.6; Impact Factor 2022=1.6; Typ=Journal Article; Shumilov E, Vehling-Kaiser U, Damnali G, Schulz X, Kaiser U, Bacher U, Kaiser F

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 515601

Second cancer after adjuvant chemotherapy in patients with colon cancer

J Clin Oncol 2022; 40 Suppl S(4): ; Impact Factor=45.3; Impact Factor 2022=45.3; Typ=Meeting Abstract;

Teufel A, Li MY, Gerken M, Ebert MP, Schlitt HJ, Evert M, Herr W, Klinkhammer-Schalke M Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 501993

Monitoring B cell alloresponses in rats.

J Immunol Methods 2022; 501(): ; Impact Factor=2.2; Impact Factor 2022=2.2; Typ=Journal Article;Research Support, Non-U.S. Gov't;

Steines L, Scharf M, Hoffmann P, Schuster A, Banas B, Bergler T Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523221

INTEGRATED SINGLE-CELL PROFILING DISSECTS CELL-STATE-SPECIFIC ENHANCER LANDSCAPES OF HUMAN TUMOR-INFILTRATING T CELLS

J Immunother Cancer 2022; 10 Suppl 1(): A16-A16; Impact Factor=10.9; Impact Factor 2022=10.9; Typ=Meeting Abstract;

Schmidl C, Riegel D, Romero-Fernandez E, Simon M, Adenugba A, Singer K, Mayr R, Weber F, Imbusch CD, Kreutz M, Brors B, Ugele I, Werner JM, Siska PJ

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 506558

Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation.

J Immunother Cancer 2022; 10(5): ; Impact Factor=10.9; Impact Factor 2022=10.9; Typ=Journal Article;Research Support, Non-U.S. Gov't;

Sorrentino A, Menevse AN, Michels T, Volpin V, Durst FC, Sax J, Xydia M, Hussein A, Stamova S, Spoerl

 

S, Heuschneider N, Muehlbauer J, Jeltsch KM, Rathinasamy A, Werner-Klein M, Breinig M, Mikietyn D, Kohler C, Poschke I, Purr S, Reidell O, Martins Freire C, Offringa R, Gebhard C, Spang R, Rehli M, Boutros M, Schmidl C, Khandelwal N, Beckhove P

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 496338

Contribution of High Viral Loads, Detection of Viral Antigen and Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity.

J Infect Dis 2022; 225(2): 190-198; Impact Factor=6.4; Impact Factor 2022=6.4; Typ=Journal Article;Research Support, Non-U.S. Gov't;

Buder F, Bauswein M, Magnus CL, Audebert F, Lang H, Kundel C, Distler K, Reuschel E, Lubnow M, Müller T, Lunz D, Graf B, Schmid S, Müller M, Poeck H, Hanses F, Salzberger B, Peterhoff D, Wenzel JJ, Schmidt B, Lampl BMJ

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 506609

Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities.

J Pers Med 2022; 12(8): ; Impact Factor=n.a.; Impact Factor 2022=n.a.; Typ=Journal Article; Scheiter A, Hierl F, Winkel I, Keil F, Klier-Richter M, Coulouarn C, Lüke F, Kandulski A, Evert M, Dietmaier W, Calvisi DF, Utpatel K

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523083

Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis. Leuk Lymphoma 2022; 63(12): 2858-2868; Impact Factor=2.6; Impact Factor 2022=2.6; Typ=Journal Article;

 Harrer DC, Jakob M, Vogelhuber M, Lüke F, Utpatel K, Corbacioglu S, Herr W, Reichle A, Heudobler

 D

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 476707

Structure-function relationships of the disease-linked A218T oxytocin receptor variant.

Mol Psychiatry 2022; 27(2): 907-917; Impact Factor=11.0; Impact Factor 2022=11.0; Typ=Journal Article;

Meyer M, Jurek B, Alfonso-Prieto M, Ribeiro R, Milenkovic VM, Winter J, Hoffmann P, Wetzel CH, Giorgetti A, Carloni P, Neumann ID

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528781

Postmitotic differentiation of human monocytes requires cohesin-structured chromatin. Nat Commun 2022; 13(1): ; Impact Factor=16.6; Impact Factor 2022=16.6; Typ=Journal Article;Research Support, Non-U.S. Gov't;

 Minderjahn J, Fischer A, Maier K, Mendes K, Nuetzel M, Raithel J, Stanewsky H, Ackermann U, Månsson R, Gebhard C, Rehli M

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) fehlt

 

ID: 523216

Expert opinion

Nat Genet 2022; 54(10): 1454-1454; Impact Factor=30.8; Impact Factor 2022=30.8; Typ=Editorial Material;

 

 Rehli M

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523191

Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain.

Oncogene 2022; 41(46): 5008-5019; Impact Factor=8.0; Impact Factor 2022=8.0; Typ=Journal Article;Research Support, Non-U.S. Gov't;

 Blazquez R, Chuang HN, Wenske B, Trigueros L, Wlochowitz D, Liguori R, Ferrazzi F, Regen T, Proescholdt MA, Rohde V, Riemenschneider MJ, Stadelmann C, Bleckmann A, Beißbarth T, van Rossum D, Hanisch UK, Pukrop T

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 497928

T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. Oncoimmunology 2022; 11(1): ; Impact Factor=7.2; Impact Factor 2022=7.2; Typ=Journal Article; Pinkert J, Boehm HH, Trautwein M, Doecke WD, Wessel F, Ge Y, Gutierrez EM, Carretero R, Freiberg C, Gritzan U, Luetke-Eversloh M, Golfier S, Von Ahsen O, Volpin V, Sorrentino A, Rathinasamy A, Xydia M, Lohmayer R, Sax J, Nur-Menevse A, Hussein A, Stamova S, Beckmann G, Glueck JM, Schoenfeld D, Weiske J, Zopf D, Offringa R, Kreft B, Beckhove P, Willuda J

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523081

A prospective, open-label, multi-centre phase II study to investigate the safety and efficacy of a combination therapy with nivolumab, ipilimumab and bevacizumab together with 2 cycles of induction chemotherapy in patients with non-squamosisNSCLC with brain metastases (CA209-7WF/Break B5) Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 208-209; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 Heudobler D, Schulz C, Illerhaus G, Janning M, Griesinger F, Lueke F, Herr W, Pukrop T Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523080

Atypical manifestations of chronic graft-versus-host disease - a retrospective unicentric analysis Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 244-244; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 Doering J, Fante M, Kattner AS, Kaiser U, Weber D, Holler B, Poeck H, Holler E, Herr W, Edinger

 M, Wolff D

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523194

First results of a comprehensive needs, quality of life and symptom creeening (NQS(2)) of cancer patients and resulting care in the daily routine of an interdisciplinary day hospital

Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 216-216; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 Pukrop T, Windschuttl S, Mueller K, Huppertz G, Herrmann-Johns A, Einhell S, Koller M Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523213

Improvement of CAR-T cell effectiveness using polyclonal Genome modifications and modulators of the innate immune system

Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 171-171; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 

 Perl M, Knoedler L, Becker LM, Shah D, Schmidl C, Poeck H Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523219

Increased CD47 expression inhibits phagocytosis of alloreactive donor T cells after allo-HSCT Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 245-245; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

Flamann C, Matos C, Kreutz M, Shaikh H, Beilhack A, Buettner-Herold M, Lischer C, Voelkl S, Kellner C, Zeun J, Kremer A, Bitterer K, Saul D, Mougiakakos D, Mackensen A, Bruns H

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 529297

Long-term survival in multiple metastatic cervical cancer-12 years after administration of paclitaxel/topotecan/bevacizumab

Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 210-211; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 Kaiser U, Rieger L, Holzapfel K, Kaiser F, Damnali G, Bochnia-Rieder B, Vehling-Kaiser U Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523178

Microbial Metabolites induce epithelial Regeneration by Activating the STING Signaling Pathway in Mice and Humans and protect against Graft versus Host Disease

Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 184-184; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 Goettert S, Orberg TE, Fan K, Ghimire S, Meedt E, Haller D, Heidegger S, Holler E, Poeck H Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523188

Molecular consensus subtyping of colorectal carcinoma In liver and brain metastases

Oncology Research and Treatment 2022; 45 Suppl 3(SUPPL 3): 72-72; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

Krekeler C, Irmer B, Sivaloganathan S, Menck K, Peeck M, Wlochowitz D, Conradi LC, Wachter A, Bayerlova M, Wolff A, Schildhaus HU, Stadelmann-Nessler C, Proescholdt M, Homayounfar K, Pukrop

 T, Beissbarth T, Bleckmann A

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523082

Overcoming CAR-T cell depletion and improving antitumor efficacy in hematologic neoplasia by polyclonal genomic modification

Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 170-170; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 Knoedler L, Perl M, Becker L, Herr W, Schmidl C, Poeck H

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 519251

PET-Guided Treatment in Patients with Early-Stage Favorable Hodgkin Lymphoma: Follow-up Analysis of the HD16 Trial by the German Hodgkin Study Group

Oncology Research and Treatment 2022; 45 Suppl 3(SUPPL 3): 168-168; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

Jacob AS, Fuchs M, Kaul H, Kobe C, Pabst T, Greil R, Eichenauer D, Topp M, Just M, Hertenstein B, Schaub V, Vogelhuber M, Zijlstra JM, Pluetschow A, Baues C, Rosenwald A, Dietlein M, Borchmann P,

 

Engert A

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 514269

Recording of the regional Origin Areas of Patients from the Molecular Tumor Board to Identify the "white Spots" in the Service Area - A joint Initiative of the Bavarian CCC WERA Alliance

Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 14-15; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 Lueke F, Haller F, Utpatel K, Krebs M, Meidenbauer N, Scheiter A, Spoerl S, Heudobler D, Keil F, Schubart C, Toegel L, Einhell S, Dietmaier W, Huss R, Dintner S, Sommer S, Jordan F, Goebeler ME, Metz M, Haake D, Scheytt M, Gerhard-Hartmann E, Maurus K, Braendlein S, Rosenwald A, Hartmann A, Maerkl B, Einsele H, Mackensen A, Herr W, Kunzmann V, Bargou R, Beckmann M, Pukrop T, Trepel M, Evert M, Claus R, Kerscher A

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523214

Reprogramming the Biogenesis and immunomodulatory Function of extracellular Tumor Vesicles through Activation of the RIG-I Pathway

Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 261-261; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

Stritzke F, Dahl S, Dassler-Plenker J, Joachim L, Buschmann D, Giebel B, Bassermann F, Coch C, Hartmann G, Heidegger S, Poeck H

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523217

Single-cell Transcriptome Analysis and clonal Kinetics in a Patient after CD19.CAR-T Cell Therapy Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 125-125; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

Lischer C, Eisenhauer N, Aigner M, Jacobs B, Schletter M, Gebhard C, Rehli M, Bruns H, Muller F, Mackensen A, Gonzalez JV, Volkl S

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 529296

The COVID-19 Flyer for Patients from Hematology and Oncology - Published by the Working Group on Patient Safety and Patient Adherence of the DGHO

Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 131-131; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 Kaiser U, Woermann B, Kaiser F, Woehr M, Oldenburg M, Hoffmann A, Damnali G, Heinecke S, Osburg S, Binder C, Bochnia-Rieder B, Fiedler M, Vehling-Kaiser U

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523220

The onco metabolite hydroxyglutarate supports an anti-glycolytic Warburg phenotype with low MHC class II expression

Oncology Research and Treatment 2022; 45 Suppl 2(SUPPL 2): 117-117; Impact Factor=2.4; Impact Factor 2022=2.4; Typ=Meeting Abstract;

 Hammon K, Renner-Sattler K, Thomas S, Kreutz M

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523198

Thoracic oncology-metastatic stages

Onkologe 2022; 28 Suppl 1(SUPPL 1): 55-60; Impact Factor=n.a.; Impact Factor 2022=n.a.;

 

Typ=Article;

Roeper J, Frost N, Wermke M, Saalfeld FC, Heudobler D, Pukrop T, Janning M, Kuon J, Fischer R, Nogova L, Christopoulos P,  Griesinger F

Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528364

SAPV patients in the COVID-19 crisis An interview-based study of palliative care patients' experiences

Onkologie 2022; 28(8): 701-707; Impact Factor=n.a.; Impact Factor 2022=n.a.; Typ=Article;

 Kaiser U, Vehling-Kaiser U, Kalteis M, Hoffmann A, Schmidt J, Kaiser F Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523874

Systemic therapy of necrobiotic xanthogranuloma: a systematic review.

Orphanet J Rare Dis 2022; 17(1): ; Impact Factor=3.7; Impact Factor 2022=3.7; Typ=Journal Article;Review;Systematic Review;

Steinhelfer L, Kühnel T, Jägle H, Mayer S, Karrer S, Haubner F, Schreml S Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 528363

Consequences of the Corona crisis on outpatient oncological care - a qualitative study among nurses and medical assistants.

PLoS ONE 2022; 17(10): ; Impact Factor=3.7; Impact Factor 2022=3.7; Typ=Journal Article;

 Kaiser U, Vehling-Kaiser U, Schmidt J, Hoffmann A, Kaiser F Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 518651

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.

PLoS ONE 2022; 17(8): ; Impact Factor=3.7; Impact Factor 2022=3.7; Typ=Journal Article;

Lubnow M, Berger J, Schneckenpointner R, Zeman F, Lunz D, Philipp A, Foltan M, Lehle K, Heimerl S,

 Hart C, Schmid C, Fisser C, Müller T

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) fehlt

 

ID: 529294

Inpatient Hospices in Germany: Medical Care Situation and Use of Supportive Oncological Therapies for Symptom Control in Tumor Patients.

Palliat Med Rep 2022; 3(1): 169-180; Impact Factor=2.5; Impact Factor 2022=2.5; Typ=Journal Article;

 Kaiser U, Vehling-Kaiser U, Hoffmann A, Kaiser F Medline-ID vorhanden, Web of Science-ID (ISI-LOC) fehlt

 

ID: 528780

Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy.

Proc Natl Acad Sci U S A 2022; 119(40): ; Impact Factor=11.1; Impact Factor 2022=11.1; Typ=Journal Article;Research Support, Non-U.S. Gov't;

Bittner S, Ruhland B, Hofmann V, Schmidleithner L, Schambeck K, Pant A, Stüve P, Delacher M, Echtenacher B, Edinger M, Hoffmann P, Rehli M, Gebhard C, Strieder N, Hehlgans T, Feuerer M Medline-ID vorhanden, Web of Science-ID (ISI-LOC) fehlt

 

ID: 518150

Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation. Radiat Oncol 2022; 17(1): ; Impact Factor=3.6; Impact Factor 2022=3.6; Typ=Journal Article;

 

Gruber I, Koelbl O, Herr W, Holler E, Edinger M, Wolff D Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 487088

Self-reported fatigue in patients with rheumatoid arthritis compared to patients with cancer: results from two large-scale studies.

Rheumatol Int 2022; 42(2): 329-339; Impact Factor=4.0; Impact Factor 2022=4.0; Typ=Journal Article; Müller K, Kuipers JG, Weis J, Fischer I, Pukrop T, Rüffer JU, Koller M

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 521198

Physiological levels of 25-hydroxyvitamin D3 induce a suppressive CD4+ T cell phenotype not reflected in the epigenetic landscape.

Scand J Immunol 2022; 95(5): ; Impact Factor=3.7; Impact Factor 2022=3.7; Typ=Journal Article;

 Matos C, Renner K, Peuker A, Schoenhammer G, Schreiber L, Bruss C, Eder R, Bruns H, Flamann C, Hoffmann P, Gebhard C, Herr W, Rehli M, Peter K, Kreutz M

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 518652

Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success.

Tomography 2022; 9(1): 50-59; Impact Factor=1.9; Impact Factor 2022=1.9; Typ=Journal Article; Pausch AM, Ghali T, Wertheimer T, Zeman F, Mueller K, Doppler MC, Einspieler I, Beyer LP, Schleder S, Stroszczynski C, Luerken L

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 506512

Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients.

Transfusion 2022; 62(8): 1602-1611; Impact Factor=2.9; Impact Factor 2022=2.9; Typ=Journal Article;

 Harrer DC, Heidenreich M, Fante MA, Müller V, Haehnel V, Offner R, Burkhardt R, Herr W, Edinger M,

 Wolff D, Thomas S, Brosig A

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523185

Age Alone Does Not Matter?!

Transplant Cell Ther 2022; 28(1): 3-4; Impact Factor=3.2; Impact Factor 2022=3.2; Typ=Journal Article;

 Wolff D

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 519056

High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group.

Transplant Cell Ther 2022; 28(6): 337.e1-337.e10; Impact Factor=3.2; Impact Factor 2022=3.2; Typ=Journal Article;Multicenter Study;

Schaffrath J, Brummer C, Wolff D, Holtick U, Kröger N, Bornhäuser M, Kraus S, Hilgendorf I, Blau IW, Penack O, Wittke C, Steiner N, Nachbaur D, Thurner L, Hindahl H, Zeiser R, Maier CP, Bethge W, Müller LP

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 519200

Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.

 

Transplant Cell Ther 2022; 28(12): 834-842; Impact Factor=3.2; Impact Factor 2022=3.2; Typ=Multicenter Study;Journal Article;Research Support, Non-U.S. Gov't;

Beelen DW, Arnold R, Stelljes M, Alakel N, Brecht A, Bug G, Bunjes D, Faul C, Finke J, Franke GN,

 Holler E, Kobbe G, Kröger N, Rösler W, Scheid C, Schönland S, Stadler M, Tischer J, Wagner-Drouet E, Wendelin K, Brüggemann M, Reiser L, Hoelzer D, Gökbuget N

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 501817

Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.

Transplant Cell Ther 2022; 28(6): 335.e1-335.e17; Impact Factor=3.2; Impact Factor 2022=3.2; Typ=Journal Article;

Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 520817

Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Transplant Cell Ther 2022; 28(8): 426-445; Impact Factor=3.2; Impact Factor 2022=3.2; Typ=Case Reports;Journal Article;Review;Research Support, Non-U.S. Gov't;Research Support, N.I.H., Intramural; Cuvelier GDE, Schoettler M, Buxbaum NP, Pinal-Fernandez I, Schmalzing M, Distler JHW, Penack O, Santomasso BD, Zeiser R, Angstwurm K, MacDonald KPA, Kimberly WT, Taylor N, Bilic E, Banas B, Buettner-Herold M, Sinha N, Greinix HT, Pidala J, Schultz KR, Williams KM, Inamoto Y, Cutler C, Griffith LM, Lee SJ, Sarantopoulos S, Pavletic SZ, Wolff D

Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

 

ID: 523222

An Attenuated Strain of Human Cytomegalovirus for the Establishment of a Subviral Particle Vaccine. Vaccines (Basel) 2022; 10(8): ; Impact Factor=7.8; Impact Factor 2022=7.8; Typ=Journal Article; Krauter S, Büscher N, Bräuchle E, Ortega Iannazzo S, Penner I, Krämer N, Gogesch P,  Thomas S,

 Kreutz M, Dejung M, Freiwald A, Butter F, Waibler Z, Plachter B Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 498175
CaMKIIδ Met281/282 oxidation is not required for recovery of calcium transients during acidosis.
Am J Physiol Heart Circ Physiol
2021; 320(3): H1199-H1212; Impact Factor=n.a.; Impact Factor2020=4.733; Typ=Journal Article;Research Support, Non-U.S. Gov't;
Kreitmeier KG, Tarnowski D, Nanadikar MS, Baier MJ, Wagner S, Katschinski DM, Maier LS, Sag CM Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 426439
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
Ann Hematol 2021; 100(3): 779-787; Impact Factor=n.a.; Impact Factor 2020=3.673; Typ=JournalArticle;Multicenter Study;
Wertheimer T, Dohse M, Afram G, Weber D, Heidenreich M, Holler B, Kattner AS, Neubauer A,Mielke S, Ljungman P, Holler E, Herr W, Edinger M , Martínez AP, Fante M, Wolff D
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 483608
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem celltransplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis onbehalf of the German Cooperative Transplant Study Group.
Ann Hematol 2021; 100(8): 2141-2142; Impact Factor=n.a.; Impact Factor 2020=3.673; Typ=PublishedErratum; Schuler E, Wagner-Drouet EM, Ajib S, Bug G, Crysandt M, Dressler S, Hausmann A, Heidenreich D,Hirschbühl K, Hoepting M, Jost E, Kaivers J, Klein S, Koldehoff M, Kordelas L, Kriege O, Müller LP,Rautenberg C, Schaffrath J, Schmid C, Wolff D, Haas R, Bornhäuser M, Schroeder T, Kobbe G,German Cooperative Transplant Study Group
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 348886
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantationwith venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of theGerman Cooperative Transplant Study Group.
Ann Hematol 2021; 100(4): 959-968; Impact Factor=n.a.; Impact Factor 2020=3.673; Typ=JournalArticle;
Schuler E, Wagner-Drouet EM, Ajib S, Bug G, Crysandt M, Dressler S, Hausmann A, Heidenreich D,Hirschbühl K,
Hoepting M, Jost E, Kaivers J, Klein S, Koldehoff M, Kordelas L, Kriege O, Müller LP,Rautenberg C, Schaffrath J, Schmid C, Wolff D, Haas R, Bornhäuser M, Schroeder T, Kobbe G,German Cooperative Transplant Study Group
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 483315
BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediatedin vivo expansion in patients with CLDN6+advanced solid tumors
Ann Oncol 2021; 32 Suppl 7(): S1392-S1392; Impact Factor=n.a.; Impact Factor 2020=32.976;Typ=Meeting Abstract; Haanen J, Mackensen A, Koenecke C, Alsdorf W, Desuki A, Wagner-Drouet E, Heudobler D, Borchmann P, Wiegert E, Schulz C, Rengstl B, Preussner L, Tuereci O, Sahin U
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 492569
A qualitative study on patients' and their support persons' preferences for receiving one longer consultation or two shorter consultations when being informed about allogeneic hematopoietic stem cell transplantation.
BMC Health Serv Res 2021; 21(1): ; Impact Factor=n.a.; Impact Factor 2020=2.655; Typ=Journal Article; Herrmann A, Holler E, Edinger M, Eickmann S, Wolff D
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501712
Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML. Blood 2021; 138(2): 160-177; Impact Factor=n.a.; Impact Factor 2020=22.113; Typ=Journal
Article;Research Support, N.I.H., Extramural;Research Support, Non-U.S. Gov't;
Mulet-Lazaro R, van Herk S, Erpelinck C, Bindels E, Sanders MA, Vermeulen C, Renkens I, Valk P, Melnick AM, de Ridder J, Rehli M, Gebhard C, Delwel R, Wouters BJ
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501434
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.
Blood 2021; 138(19): 1830-1842; Impact Factor=n.a.; Impact Factor 2020=22.113; Typ=Journal Article;Research Support, Non-U.S. Gov't;
Jetani H, Navarro-Bailón A, Maucher M, Frenz S, Verbruggen C, Yeguas A, Vidriales MB, González M, Rial Saborido J, Kraus S, Mestermann K, Thomas S, Bonig H, Luu M, Monjezi R, Mougiakakos D, Sauer M, Einsele H, Hudecek M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 428934
Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease.
Blood 2021; 137(17): 2403-2416; Impact Factor=n.a.; Impact Factor 2020=22.113; Typ=Journal Article; Zhang Y, Shen L, Dreissigacker K, Zhu H, Trinh-Minh T, Meng X, Tran-Manh C, Dees C, Matei AE, Chen CW, Ditschkowski M, Krauss S, Winkler J, Wolff D, Ziemer M, Beilhack A, Karrer S, Herr W, Mackensen A, Schett G, Spriewald BM, Distler JHW
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 218726
1,25-dihydroxyvitamin-D3 but not the clinically applied marker 25-hydroxyvitamin-D3 predicts survival after stem cell transplantation.
Bone Marrow Transplant 2021; 56(2): 419-433; Impact Factor=n.a.; Impact Factor 2020=5.483;
Typ=Journal Article;
Peter K, Siska PJ, Roider T, Matos C, Bruns H, Renner K, Singer K, Weber D, Güllstorf M, Kröger N, Wolff D, Herr W, Ayuk F, Holler E, Stark K, Heid IM, Kreutz M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501609
Acute And Chronic Graft-Versus-Host-Disease Impair B-Cell Reconstitution in Allogeneic-Transplanted Patients at Different Maturation Stages
Bone Marrow Transplant 2021; 56 Suppl 1(SUPPL 1): 217-217; Impact Factor=n.a.; Impact Factor 2020=5.483; Typ=Meeting Abstract; Fante MA, Weigert V, Hoffmann P, Fehn U, Winkler T, Winkler J, Herr W, Edinger M, Wolff D
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 500321
Microbial-Derived Metabolites Induce Epithelial Recovery Via The Sting Pathway in Mice and Men and Protect From Graft-Versus-Host Disease
Bone Marrow Transplant 2021; 56 Suppl 1(SUPPL 1): 87-89; Impact Factor=n.a.; Impact Factor 2020=5.483; Typ=Meeting Abstract;
Orberg ET, Goettert S, Pianka A, Hiergeist A, Gessner A, Heidegger S, Herr W, Poeck H
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 421916
Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.
Bone Marrow Transplant 2021; 56(1): 243-256; Impact Factor=n.a.; Impact Factor 2020=5.483;
Typ=Journal Article; Wolff D, Herzberg PY, Herrmann A, Pavletic SZ, Heussner P, Mumm F, Höfer C, Hilgendorf I, Hemmati PG, Holler E, Greinix H, Mitchell SA
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 469407
Prolonged Suppression of Butyrate Producing Bacteria Indicates Dysbiosis And is Associated with Acute Gastrointestinal Graft-Versus-Host Disease And Transplant Related Mortality After Allogeneic Stem Cell Transplantation
Bone Marrow Transplant 2021; 56 Suppl 1(SUPPL 1): 217-218; Impact Factor=n.a.; Impact Factor 2020=5.483; Typ=Meeting Abstract; Meedt E, Hiergeist A, Gessner A, Dettmer-Wilde K, Liebisch G, Ghimire S, Poeck H, Edinger M, Wolff D, Herr W, Holler E, Weber D
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 501739
Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Bone Marrow Transplant 2021; 56(9): 2079-2087; Impact Factor=n.a.; Impact Factor 2020=5.483; Typ=Journal Article;Research Support, Non-U.S. Gov't;Review; Wolff D, Fatobene G, Rocha V, Kröger N, Flowers ME
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501723
The Magnitude of Intestinal T Cell Infiltration Determines Epithelial Regeneration During Immune-Mediated Tissue Injury
Bone Marrow Transplant 2021; 56 Suppl 1(SUPPL 1): 231-232; Impact Factor=n.a.; Impact Factor 2020=5.483; Typ=Meeting Abstract;
Goettert S, Fischer J, Eisenkolb G, Engleitner T, Orberg ET, Heidegger S, Poeck H
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 414497
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.
Bone Marrow Transplant 2021; 56(5): 1171-1179; Impact Factor=n.a.; Impact Factor 2020=5.483; Typ=Journal Article;
Styczy?ski J, Tridello G, Xhaard A, Medinger M, Mielke S, Taskinen M, Blijlevens N, Rodriguez MAB, Solano C, Nikolousis E, Biffi A, Groll AH, Junghanss C, Tsirigotis P, Lioure B, ?rámek J, Holler E, Galaverna F, Fagioli F, Knelange N, Wendel L, Gil L, de la Camara R, Mikulska M, Ljungman P
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 493687
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
Br J Haematol 2021; 193(3): 592-601; Impact Factor=n.a.; Impact Factor 2020=6.998; Typ=Clinical Trial;Journal Article;Observational Study;
Kharfan-Dabaja MA, Labopin M, Brissot E, Kroger N, Finke J, Ciceri F, Deconinck E, Blaise D, Chevallier P, Gramatzki M, Ganser A, Stelljes M, Edinger M, Savani B, Ruggeri A, Sanz J, Nagler A, Mohty M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 427466
Brain Metastases in Elderly Patients-The Role of Surgery in the Context of Systemic Treatment.
Brain Sci 2021; 11(1): ; Impact Factor=n.a.; Impact Factor 2020=3.394; Typ=Journal Article; Proescholdt M, Jünger ST, Schödel P, Schebesch KM, Doenitz C, Pukrop T, Höhne J, Schmidt NO, Kocher M, Schulz H, Ruge M, König K, Goldbrunner R, Grau S
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501734
Metabolic profiles of regulatory T cells in the tumour microenvironment.
Cancer Immunol Immunother 2021; 70(9): 2417-2427; Impact Factor=n.a.; Impact Factor 2020=6.968; Typ=Journal Article;Review;
Rao D, Verburg F, Renner K, Peeper DS, Lacroix R, Blank CU
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 421398
The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.
Cancer Immunol Res 2021; 9(3): 265-278; Impact Factor=n.a.; Impact Factor 2020=11.151;
Typ=Journal Article;
Mougiakakos D, Bach C, Böttcher M, Beier F, Röhner L, Stoll A, Rehli M, Gebhard C, Lischer C, Eberhardt M, Vera J, Büttner-Herold M, Bitterer K, Balzer H, Leffler M, Jitschin S, Hundemer M, Awwad MHS, Busch M, Stenger S, Völkl S, Schütz C, Krönke J, Mackensen A, Bruns H
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 419027
The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients.
Cancer Lett 2021; 499(): 209-219; Impact Factor=n.a.; Impact Factor 2020=8.679; Typ=Journal Article; Spanier G, Ugele I, Nieberle F, Symeou L, Schmidhofer S, Brand A, Meier J, Spoerl S, Krupar R, Rümmele P, Siska P, Renner K, Peter K, Gerken M, Beckhove P, Reichert TE, Kreutz M, Singer K
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 497015
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite.
Cancers (Basel) 2021; 13(8): ; Impact Factor=n.a.; Impact Factor 2020=6.639; Typ=Journal Article; Berger RS, Wachsmuth CJ, Waldhier MC, Renner-Sattler K, Thomas S, Chaturvedi A, Niller HH, Bumes E, Hau P, Proescholdt M, Gronwald W, Heuser M, Kreutz M, Oefner PJ, Dettmer K
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501732
Moderate Altitude Residence Reduces Male Colorectal and Female Breast Cancer Mortality More Than Incidence: Therapeutic Implications?
Cancers (Basel) 2021; 13(17): ; Impact Factor=n.a.; Impact Factor 2020=6.639; Typ=Journal Article; Burtscher J, Millet GP, Renner-Sattler K, Klimont J, Hackl M, Burtscher M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 494447
Targeting Cancer Metabolism Breaks Radioresistance by Impairing the Stress Response.
Cancers (Basel) 2021; 13(15): ; Impact Factor=n.a.; Impact Factor 2020=6.639; Typ=Journal Article; Schwab M, Thunborg K, Azimzadeh O, von Toerne C, Werner C, Shevtsov M, Di Genio T, Zdralevic M, Pouyssegur J, Renner K, Kreutz M, Multhoff G
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501728
The Management of Brain Metastases-Systematic Review of Neurosurgical Aspects.
Cancers (Basel) 2021; 13(7): ; Impact Factor=n.a.; Impact Factor 2020=6.639; Typ=Journal
Article;Review; Proescholdt MA, Schödel P, Doenitz C, Pukrop T, Höhne J, Schmidt NO, Schebesch KM
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 474003
Parametric Imaging of Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Acute Gastrointestinal Graft-Versus-Host Disease.
Cells 2021; 10(5): ; Impact Factor=n.a.; Impact Factor 2020=6.6; Typ=Journal Article;Research Support, Non-U.S. Gov't;
Pausch AM, Kammerer S, Weber F, Herr W, Stroszczynski C, Holler E, Edinger M, Wolff D, Weber D, Jung EM, Wertheimer T
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 382710
Interstitial lung opacities in patients with severe COVID-19 pneumonia by bedside high-resolution ultrasound in association to CO2 retention.
Clin Hemorheol Microcirc 2021; 77(4): 355-365; Impact Factor=n.a.; Impact Factor 2020=2.375; Typ=Journal Article;
Peschel G, Jung EM, Fisser C, Putz FJ, Wertheimer T, Sinner B, Lunz D, Jung F, Müller M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501617
Outcome of Relapsed or Refractory Acute B-Lymphoblastic Leukemia Patients with Extramedullary Disease Receiving Inotuzumab Ozogamicin
Clin Lymphoma Myeloma Leuk 2021; 21 Suppl 1(): S265-S265; Impact Factor=n.a.; Impact Factor 2020=3.231; Typ=Meeting Abstract;
Kayser S, Sartor C, Panitz N, Fante M, Lutz C, Wolff D, Ho A, Papayannidis C
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 465379
Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centers.
Clin Nutr 2021; 40(4): 1571-1577; Impact Factor=n.a.; Impact Factor 2020=7.324; Typ=Journal Article; Toenges R, Greinix H, Lawitschka A, Halter J, Baumgartner A, Simon A, Arends J, Jäger P, Middeke M, Hilgendorf I, Klein S, Wagner-Drouet EM, Schmid C, Bug G, Wolff D, German-Austrian-Swiss GVHD consortium
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 485421
The impact of epicardial adipose tissue in patients with acute myocardial infarction (May,10.1007/s00392-021-01865-4, 2021)
Clin Res Cardiol 2021; (): ; Impact Factor=n.a.; Impact Factor 2020=5.46; Typ=Fisser C, Colling S, Debl K, Hetzenecker A, Sterz U, Hamer OW, Fellner C, Maier LS, Buchner S, Arzt M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 485422
The impact of epicardial adipose tissue in patients with acute myocardial infarction.
Clin Res Cardiol 2021; 110(10): 1637-1646; Impact Factor=n.a.; Impact Factor 2020=5.46; Typ=Journal Article;
Fisser C, Colling S, Debl K, Hetzenecker A, Sterz U, Hamer OW, Fellner C, Maier LS, Buchner S, Arzt M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 430048
Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy.
Curr Oncol 2021; 28(2): 1161-1169; Impact Factor=n.a.; Impact Factor 2020=3.677; Typ=Case Reports; Scheiter A, Keil F, Lüke F, Grosse J, Verloh N, Opitz S, Schlosser S, Kandulski A, Pukrop T, Dietmaier W, Evert M, Calvisi DF, Utpatel K
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 426081
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation.
Diagnostics (Basel) 2021; 11(2): ; Impact Factor=n.a.; Impact Factor 2020=3.706; Typ=Journal Article; Wagner-Drouet E, Teschner D, Wolschke C, Schäfer-Eckart K, Gärtner J, Mielke S, Schreder M, Kobbe G, Hilgendorf I, Klein S, Verbeek M, Ditschkowski M, Koch M, Lindemann M, Schmidt T, Rascle A, Barabas S, Deml L, Wagner R, Wolff D
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 470070
Sleep apnoea and incident malignancy in type 2 diabetes.
ERJ Open Res 2021; 7(2): ; Impact Factor=n.a.; Impact Factor 2020=n.a.; Typ=Journal Article; Driendl S, Arzt M, Zimmermann CS, Jung B, Pukrop T, Böger CA, Haferkamp S, Zeman F, Heid IM, Stadler S
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 498177
Mitochondrial dysfunction in tachycardiomyopathy
Eur J Heart Fail 2021; 23 Suppl 1(): 11-11; Impact Factor=n.a.; Impact Factor 2020=15.534;
Typ=Meeting Abstract; Paulus M, Renner K, Pabel S, Zuegner E, Magnes C, Pietrzyk G, Riedl D, Luchner A, Birner C, Wagner S, Maier LS, Streckfuss-Boemeke K, Sossalla ST, Dietl A
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 501724
Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice.
Eur J Immunol 2021; 51(6): 1531-1534; Impact Factor=n.a.; Impact Factor 2020=5.532;
Typ=Letter;Research Support, Non-U.S. Gov't; Poeck H, Wintges A, Dahl S, Bassermann F, Haas T, Heidegger S
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501722
UVA induced changes in glucose metabolism in dermal cells could be part of a cellular antioxidant strategy
Exp Dermatol 2021; 30(3): E85-E85; Impact Factor=n.a.; Impact Factor 2020=3.96; Typ=Meeting Abstract;
Ivanova I, Hartwig M, Hartwig A, Arndt S, Gronwald W, Kreutz M, Kamenisch Y, Berneburg M
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 499513
GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.
Front Immunol 2021; 12(): ; Impact Factor=n.a.; Impact Factor 2020=7.561; Typ=Journal
Article;Research Support, Non-U.S. Gov't;
Ghimire S, Weber D, Hippe K, Meedt E, Hoepting M, Kattner AS, Hiergeist A, Gessner A, Matos C, Ghimire S, Wolff D, Edinger M, Hoffmann P, Poeck H, Herr W, Holler E
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501721
Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease.
Front Immunol 2021; 12(): ; Impact Factor=n.a.; Impact Factor 2020=7.561; Typ=Journal
Article;Research Support, Non-U.S. Gov't; Crossland RE, Norden J, Ghimire S, Juric MK, Pearce KF, Lendrem C, Collin M, Mischak-Weissinger E, Holler E, Greinix HT, Dickinson AM
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501742
Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease.
Front Immunol 2021; 12(): ; Impact Factor=n.a.; Impact Factor 2020=7.561; Typ=Journal
Article;Research Support, Non-U.S. Gov't;Review; Lelas A, Greinix HT, Wolff D, Eissner G, Pavletic SZ, Pulanic D
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 426440
A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001).
Front Med (Lausanne) 2021; 7(): ; Impact Factor=n.a.; Impact Factor 2020=5.091; Typ=Journal Article; Oberbauer R, Edinger M, Berlakovich G, Kalhs P, Worel N, Heinze G, Wolzt M, Lion T, Wekerle T Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501729
Modeling and Bioinformatics Identify Responders to G-CSF in Patients With Amyotrophic Lateral Sclerosis.
Front Neurol 2021; 12(): ; Impact Factor=n.a.; Impact Factor 2020=4.003; Typ=Journal Article; Johannesen S, Huie JR, Budeus B, Peters S, Wirth AM, Iberl S, Kammermaier T, Kobor I, Wirkert E, Küspert S, Tahedl M, Grassinger J, Pukrop T, Schneider A, Aigner L, Schulte-Mattler W, Schuierer G, Koch W, Bruun TH, Ferguson AR, Bogdahn U
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

D: 494843
Case Report: Dual Checkpoint Inhibition in Advanced Metastatic Osteosarcoma Results in Remission of All Tumor Manifestations-A Report of a Stunning Success in a 37-Year-Old Patient.
Front Oncol 2021; 11(): ; Impact Factor=n.a.; Impact Factor 2020=6.244; Typ=Case Reports;
Sterz U, Grube M, Herr W, Menhart K, Wendl C, Vogelhuber M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501610
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung).
Front Pharmacol 2021; 12(): ; Impact Factor=n.a.; Impact Factor 2020=5.81; Typ=Journal Article; Heudobler D, Schulz C, Fischer JR, Staib P, Wehler T, Südhoff T, Schichtl T, Wilke J, Hahn J, Lüke F, Vogelhuber M, Klobuch S, Pukrop T, Herr W, Held S, Beckers K, Bouche G, Reichle A
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 498146
Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease.
Front Pharmacol 2021; 12(): ; Impact Factor=n.a.; Impact Factor 2020=5.81; Typ=Journal Article; Lüke F, Harrer DC, Menhart K, Wolff D, Holler E, Hellwig D, Herr W, Grube M, Vogelhuber M, Reichle A, Heudobler D
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501608
Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Front Pharmacol 2021; 12(): ; Impact Factor=n.a.; Impact Factor 2020=5.81; Typ=Journal Article; Lüke F, Harrer DC, Hahn J, Grube M, Pukrop T, Herr W, Reichle A, Heudobler D
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501717
Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis.
Front Pharmacol 2021; 12(): ; Impact Factor=n.a.; Impact Factor 2020=5.81; Typ=Editorial; Heudobler D, Reichle A, Ghibelli L
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 492563
"This Graft-vs.-Host Disease Determines My Life. That's It."-A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany.
Front Public Health 2021; 9(): ; Impact Factor=n.a.; Impact Factor 2020=3.709; Typ=Journal
Article;Research Support, Non-U.S. Gov't; Parisek M, Loss J, Holler E, Barata A, Weber D, Edinger M, Wolff D, Schoemans H, Herrmann A
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 483339
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.
Haematologica 2021; 106(12): 3100-3106; Impact Factor=n.a.; Impact Factor 2020=9.941; Typ=Journal Article;
Kayser S, Schlenk RF, Lebon D, Carre M, Götze KS, Stölzel F, Berceanu A, Schäfer-Eckart K, Peterlin P, Hicheri Y, Rahme R, Raffoux E, Chermat F, Krause SW, Aulitzky WE, Rigaudeau S, Noppeney R, Berthon C, Görner M, Jost E, Carassou P, Keller U, Orvain C, Braun T, Saillard C, Arar A, Kunzmann V, Wemeau M, De Wit M, Niemann D, Bonmati C, Schwänen C, Abraham J, Aljijakli A, Haiat S, Krämer A, Reichle A, Gnadler M, Willekens C, Spiekermann K, Hiddemann W, Müller-Tidow C, Thiede C, Röllig C, Serve H, Bornhäuser M, Baldus CD, Lengfelder E, Fenaux P, Platzbecker U, Adès L
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 217542
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.
Haematologica 2021; 106(2): 363-374; Impact Factor=n.a.; Impact Factor 2020=9.941; Typ=Journal Article;
Wagner-Drouet E, Teschner D, Wolschke C, Janson D, Schäfer-Eckart K, Gärtner J, Mielke S, Schreder M, Kobbe G, Kondakci M, Hilgendorf I, von Lilienfeld-Toal M, Klein S, Heidenreich D, Kreil S, Verbeek M, Graß S, Ditschkowski M, Gromke T, Koch M, Lindemann M, Hünig T, Schmidt T, Rascle A, Guldan H, Barabas S, Deml L, Wagner R, Wolff D
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501841
Heparanase wildtype is associated with a reduced incidence of transplant-associated systemic vasculopathies.
Hematol Oncol Stem Cell Ther 2021; (): ; Impact Factor=n.a.; Impact Factor 2020=n.a.; Typ=Journal Article;
Mueckenhausen R, Föll J, Kleinschmidt K, Tröger A, Malaisé M, Wolff D, Holler E, Matthes M, Heise T, Sommer G, Corbacioglu S
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) fehlt

ID: 491730
Stanniocalcin 1 is overexpressed in multipotent mesenchymal stromal cells from acute myeloid leukemia patients.
Hematology 2021; 26(1): 565-576; Impact Factor=n.a.; Impact Factor 2020=2.269; Typ=Journal Article; Schelker RC, Kratzer A, Müller G, Brochhausen C, Hart C, Stempfl T, Heudobler D, Moehle C, Herr W, Iberl S, Grassinger J
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 497917
Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells.
Immunity 2021; 54(4): 702-720.e17; Impact Factor=n.a.; Impact Factor 2020=31.745; Typ=Journal Article;Research Support, Non-U.S. Gov't;
Delacher M, Simon M, Sanderink L, Hotz-Wagenblatt A, Wuttke M, Schambeck K, Schmidleithner L, Bittner S, Pant A, Ritter U, Hehlgans T, Riegel D, Schneider V, Groeber-Becker FK, Eigenberger A, Gebhard C, Strieder N, Fischer A, Rehli M, Hoffmann P, Edinger M, Strowig T, Huehn J, Schmidl C, Werner JM, Prantl L, Brors B, Imbusch CD, Feuerer M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 425710
Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: Balancing immunosuppression.
Int J Infect Dis 2021; 103(): 624-627; Impact Factor=n.a.; Impact Factor 2020=3.623; Typ=Case Reports;
Lubnow M, Schmidt B, Fleck M, Salzberger B, Müller T, Peschel G, Schneckenpointner R, Lange T, Hitzenbichler F, Kieninger M, Lunz D, Graf B, Brochhausen C, Weber F, Lüke F, Peterhoff D, Schuster P, Hiergeist A, Offner R, Hehr U, Wallner S, Hanses F, Schmid S, Weigand K, Geismann F, Poeck H, Pukrop T, Evert M, Gessner A, Burkhardt R, Herr W, Maier LS, Heudobler D
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501361
Heat-Inactivation of Human Serum Destroys C1 Inhibitor, Pro-motes Immune Complex Formation, and Improves Human T Cell Function.
Int J Mol Sci 2021; 22(5): ; Impact Factor=n.a.; Impact Factor 2020=5.923; Typ=Journal Article; Fante MA, Decking SM, Bruss C, Schreml S, Siska PJ, Kreutz M, Renner K
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 496572
Causes, Possibilities for Prevention and Consequences of Delirium in internal Intensive Care Medicine
Internist (Berl) 2021; 62 Suppl 2(SUPPL 2): 171-171; Impact Factor=n.a.; Impact Factor 2020=0.743; Typ=Meeting Abstract;
Denk A, Mueller K, Kunst C, Guelow K, Mueller-Schilling M, Schmid S
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 501725
Microbial-derived metabolites induce epithelial recovery via the STING pathway in mice and men and protect from graft-versus-host disease
Internist (Berl) 2021; 62 Suppl 2(SUPPL 2): 164-164; Impact Factor=n.a.; Impact Factor 2020=0.743; Typ=Meeting Abstract;
Orberg ET, Goettert S, Pianka A, Poeck H
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 490645
Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone.
J Clin Invest 2021; 131(22): ; Impact Factor=n.a.; Impact Factor 2020=14.808; Typ=Journal Article;Research Support, Non-U.S. Gov't;
Siska PJ, Decking SM, Babl N, Matos C, Bruss C, Singer K, Klitzke J, Schön M, Simeth J, Köstler J, Siegmund H, Ugele I, Paulus M, Dietl A, Kolodova K, Steines L, Freitag K, Peuker A, Schönhammer G, Raithel J, Graf B, Geismann F, Lubnow M, Mack M, Hau P, Bohr C, Burkhardt R, Gessner A, Salzberger B, Wagner R, Hanses F, Hitzenbichler F, Heudobler D, Lüke F, Pukrop T, Herr W, Wolff D, Spang R, Poeck H, Hoffmann P, Jantsch J, Brochhausen C, Lunz D, Rehli M, Kreutz M, Renner K
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501718
Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase 2 LEAP-005 study.
J Clin Oncol 2021; 39 Suppl S(15): ; Impact Factor=n.a.; Impact Factor 2020=44.544; Typ=Meeting Abstract;
Villanueva L, Lwin Z, Chung HCC, Gomez-Roca CA, Longo F, Yanez E, Senellart H, Doherty M, Garcia-Corbacho J, Hendifar AE, Maurice-Dror C, Gill SS, Kim TW, Heudobler D, Penel N, Ghori R, Kubiak P, Jin F, Norwood KG, Graham DM
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 501719
Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase II LEAP-005 study.
J Clin Oncol 2021; 39 Suppl S(3): ; Impact Factor=n.a.; Impact Factor 2020=44.544; Typ=Meeting Abstract;
Villanueva L, Lwin Z, Chung HC, Gomez-Roca C, Longo F, Yanez E, Senellart H, Doherty M, Garcia-Corbacho J, Hendifar AE, Maurice-Dror C, Gill SS, Kim TW, Heudobler D, Penel N, Ghori R, Kubiak P, Jin F, Norwood KG, Graham D
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 501735
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation.
J Immunol 2021; 206(6): 1127-1139; Impact Factor=n.a.; Impact Factor 2020=5.422; Typ=Journal Article;Observational Study;Research Support, N.I.H., Extramural;
Healey DCC, Cephus JY, Barone SM, Chowdhury NU, Dahunsi DO, Madden MZ, Ye X, Yu X, Olszewski K, Young K, Gerriets VA, Siska PJ, Dworski R, Hemler J, Locasale JW, Poyurovsky MV, Peebles RS, Irish JM, Newcomb DC, Rathmell JC

ID: 497916
Characterization and ex vivo expansion of rare in situ cytokine secreting T cell populations from tumor tissue and blood of oral squamous cell carcinoma patients.
J Immunol Methods 2021; 496(): ; Impact Factor=n.a.; Impact Factor 2020=2.303; Typ=Comparative Study;Journal Article;
Stamova S, Ott-Rötzer B, Smetak H, Schäffler K, Eder R, Fink I, Hoffmann P, Reichert TE, Beckhove P, Spanier G
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501727
Modeling and bioinformatics identify responders to G-CSF in patients with amyotrophic lateral sclerosis.
J Neurol Sci 2021; 429 Suppl S(): 254-255; Impact Factor=n.a.; Impact Factor 2020=3.181; Typ=Meeting Abstract;
Johannesen S, Bogdahn U, Bruun TH, Huie JR, Ferguson A, Budeus B, Peters S, Wirth AM, Iberl S, Kammermaier T, Kobor I, Wirkert E, Kuespert S, Tahedl M, Grassinger J, Pukrop T, Armin S, Aigner L, Schulte-Mattler W, Schuierer G, Koch W
Medline-ID fehlt, Web of Science-ID (ISI-LOC) vorhanden

ID: 499521
STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy.
JCO Precision Oncology 2021; 5(): 1507-1513; Impact Factor=n.a.; Impact Factor 2020=4.853;
Typ=Case Reports;
Gerthofer V, Scheiter A, Lüke F, Keil F, Utpatel K, Pöhmerer LM, Seitz J, Niessen C, Ignatov A, Dietmaier W, Calvisi DF, Evert M, Ortmann O, Seitz S
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 427636
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol 2021; 22(2): 223-234; Impact Factor=n.a.; Impact Factor 2020=41.316; Typ=Clinical Trial, Phase III;Journal Article;Multicenter Study;Randomized Controlled Trial;Research Support, Non-U.S. Gov't;
Borchmann P, Plütschow A, Kobe C, Greil R, Meissner J, Topp MS, Ostermann H, Dierlamm J, Mohm J, Thiemer J, Sökler M, Kerkhoff A, Ahlborn M, Halbsguth TV, Martin S, Keller U, Balabanov S, Pabst T, Vogelhuber M, Hüttmann A, Wilhelm M, Zijlstra JM, Moccia A, Kuhnert G, Bröckelmann PJ, von Tresckow B, Fuchs M, Klimm B, Rosenwald A, Eich H, Baues C, Marnitz S, Hallek M, Diehl V, Dietlein M, Engert A
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 470669
Low dose stereotactic irradiation and dexamethasone in primary cerebral light chain deposition disease (LCDD).
Leuk Lymphoma 2021; 62(9): 2267-2271; Impact Factor=n.a.; Impact Factor 2020=3.28; Typ=Letter; Authier D, Hegenbart U, Pohl F, Rosenwald A, Kircher S, Menhart K, Perl M, Cerny J, Mayer S, Herr W, Grube M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 417096
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy.
Leukemia 2021; 35(6): 1763-1772; Impact Factor=n.a.; Impact Factor 2020=11.528; Typ=Journal Article;
Weissinger EM, Metzger J, Schleuning M, Schmid C, Messinger D, Beutel G, Wagner-Drouet EM, Schetelig J, Baurmann H, Rank A, Stolzl F, Schäfer-Eckart K, Westphal K, Bethge W, von Harsdorf S, Bunjes DW, Heidenreich D, Klein S, Holler E, Kreipe HH, Jonigk D, Türüchanow I, Raad J, Papkalla A, von der Leyen H, Hambach L, Hamwi I, Ehrlich S, Krauter J, Stadler M, Ganser A
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 428933
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Leukemia 2021; 35(9): 2517-2525; Impact Factor=n.a.; Impact Factor 2020=11.528; Typ=Journal Article;
Röllig C, Serve H, Noppeney R, Hanoun M, Krug U, Baldus CD, Brandts CH, Kunzmann V, Einsele H, Krämer A, Müller-Tidow C, Schäfer-Eckart K, Neubauer A, Burchert A, Giagounidis A, Krause SW, Mackensen A, Aulitzky W, Herbst R, Hänel M, Frickhofen N, Kullmer J, Kaiser U, Kiani A, Link H, Geer T, Reichle A, Junghanß C, Repp R, Meinhardt A, Dürk H, Klut IM, Bornhäuser M, Schaich M, Parmentier S, Görner M, Thiede C, von Bonin M, Platzbecker U, Schetelig J, Kramer M, Berdel WE, Ehninger G, Study Alliance Leukaemia (SAL)
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 383582
Associations of site-specific CD4 + -T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus.
Lupus 2021; 30(1): 45-51; Impact Factor=n.a.; Impact Factor 2020=2.911; Typ=Journal Article; Vordenbäumen S, Rosenbaum A, Gebhard C, Raithel J, Sokolowski A, Düsing C, Chehab G, Richter JG, Brinks R, Rehli M, Schneider M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 467822
Methyl donor micronutrients, CD40-ligand methylation and disease activity in systemic lupus erythematosus: A cross-sectional association study.
Lupus 2021; 30(11): 1773-1780; Impact Factor=n.a.; Impact Factor 2020=2.911; Typ=Journal Article; Vordenbäumen S, Sokolowski A, Rosenbaum A, Gebhard C, Raithel J, Düsing C, Chehab G, Richter JG, Brinks R, Rehli M, Schneider M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 469416
Application of Lipid Class Ratios for Sample Stability Monitoring-Evaluation of Murine Tissue Homogenates and SDS as a Stabilizer.
Metabolites 2021; 11(5): ; Impact Factor=n.a.; Impact Factor 2020=4.932; Typ=Journal Article; Krautbauer S, Blazquez R, Liebisch G, Hoering M, Neubert P, Pukrop T, Burkhardt R, Sigruener A Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 429450
Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients.
Nat Commun 2021; 12(1): ; Impact Factor=n.a.; Impact Factor 2020=14.919; Typ=Journal
Article;Research Support, Non-U.S. Gov't; Xydia M, Rahbari R, Ruggiero E, Macaulay I, Tarabichi M, Lohmayer R, Wilkening S, Michels T, Brown D, Vanuytven S, Mastitskaya S, Laidlaw S, Grabe N, Pritsch M, Fronza R, Hexel K, Schmitt S, Müller-Steinhardt M, Halama N, Domschke C, Schmidt M, von Kalle C, Schütz F, Voet T, Beckhove P
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 469411
Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes.
Nat Commun 2021; 12(1): ; Impact Factor=n.a.; Impact Factor 2020=14.919; Typ=Journal
Article;Research Support, Non-U.S. Gov't; Renner K, Schwittay T, Chaabane S, Gottschling J, Müller C, Tiefenböck C, Salewski JN, Winter F, Buchtler S, Balam S, Malfertheiner MV, Lubnow M, Lunz D, Graf B, Hitzenbichler F, Hanses F, Poeck H, Kreutz M, Orsó E, Burkhardt R, Niedermair T, Brochhausen C, Gessner A, Salzberger B, Mack M Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 497955
Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cells.
Nat Commun 2021; 12(1): ; Impact Factor=n.a.; Impact Factor 2020=14.919; Typ=Comparative Study;Journal Article;Research Support, Non-U.S. Gov't;
Hücker SM, Fehlmann T, Werno C, Weidele K, Lüke F, Schlenska-Lange A, Klein CA, Keller A, Kirsch S Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501713
The epigenetic pioneer EGR2 initiates DNA demethylation in differentiating monocytes at both stable and transient binding sites.
Nat Commun 2021; 12(1): ; Impact Factor=n.a.; Impact Factor 2020=14.919; Typ=Journal
Article;Research Support, Non-U.S. Gov't; Mendes K, Schmidhofer S, Minderjahn J, Glatz D, Kiesewetter C, Raithel J, Wimmer J, Gebhard C, Rehli M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 430850
[Maculopathy in sickle cell disease].
Ophthalmologe 2021; 118(10): 1013-1023; Impact Factor=n.a.; Impact Factor 2020=1.059; Typ=English Abstract;Journal Article;Review;
Bachmeier I, Blecha C, Föll J, Wolff D, Jägle H
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 469491
An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease.
PLoS ONE 2021; 16(8): ; Impact Factor=n.a.; Impact Factor 2020=3.24; Typ=Journal Article;
Kreft A, Hippe K, Wagner-Drouet EM, Ries I, Kandulski A, Büttner-Herold M, Neumann H, Weber D, Holler E, Schindeldecker M
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501813
The tumor patient in the COVID-19 pandemic-an interview-based study of 30 patients undergoing systemic antiproliferative therapy.
PLoS ONE 2021; 16(8): ; Impact Factor=n.a.; Impact Factor 2020=3.24; Typ=Journal Article;
Kaiser U, Vehling-Kaiser U, Schmidt J, Hoffmann A, Kaiser F
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501733
Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytes.
Sci Rep 2021; 11(1): ; Impact Factor=n.a.; Impact Factor 2020=4.379; Typ=Journal Article;Research Support, Non-U.S. Gov't;
Esteve-Codina A, Hofer TP, Burggraf D, Heiss-Neumann MS, Gesierich W, Boland A, Olaso R, Bihoreau MT, Deleuze JF, Moeller W, Schmid O, Soler Artigas M, Renner K, Hohlfeld JM, Welte T, Fuehner T, Jerrentrup L, Koczulla AR, Greulich T, Prasse A, Müller-Quernheim J, Gupta S, Brightling C, Subramanian DR, Parr DG, Kolsum U, Gupta V, Barta I, Döme B, Strausz J, Stendardo M, Piattella M, Boschetto P, Korzybski D, Gorecka D, Nowinski A, Dabad M, Fernández-Callejo M, Endesfelder D, Zu Castell W, Hiemstra PS, Venge P, Noessner E, Griebel T, Heath S, Singh D, Gut I, Ziegler-Heitbrock L
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501817
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Transplant Cell Ther 2021; (): ; Impact Factor=n.a.; Impact Factor 2020=n.a.; Typ=Journal Article; Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) fehlt

ID: 501741
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.
Transplant Cell Ther 2021; 27(6): 452-466; Impact Factor=n.a.; Impact Factor 2020=n.a.; Typ=Journal Article;Research Support, N.I.H., Extramural;Research Support, Non-U.S. Gov't;Review; Williams KM, Inamoto Y, Im A, Hamilton B, Koreth J, Arora M, Pusic I, Mays JW, Carpenter PA, Luznik L, Reddy P, Ritz J, Greinix H, Paczesny S, Blazar BR, Pidala J, Cutler C, Wolff D, Schultz KR, Pavletic SZ, Lee SJ, Martin PJ, Socie G, Sarantopoulos S
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501737
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.
Transplant Cell Ther 2021; 27(9): 729-737; Impact Factor=n.a.; Impact Factor 2020=n.a.; Typ=Journal Article;Research Support, N.I.H., Intramural;
DeFilipp Z, Couriel DR, Lazaryan A, Bhatt VR, Buxbaum NP, Alousi AM, Olivieri A, Pulanic D, Halter JP, Henderson LA, Zeiser R, Gooley TA, MacDonald KPA, Wolff D, Schultz KR, Paczesny S, Inamoto Y, Cutler CS, Kitko CL, Pidala JA, Lee SJ, Socie G, Sarantopoulos S, Pavletic SZ, Martin PJ, Blazar BR, Greinix HT
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 487185
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report.
Transplant Cell Ther 2021; 27(7): 545-557; Impact Factor=n.a.; Impact Factor 2020=n.a.; Typ=Journal Article;Research Support, N.I.H., Intramural;Research Support, Non-U.S. Gov't;Research Support, U.S. Gov't, Non-P.H.S.;
Kitko CL, Pidala J, Schoemans HM, Lawitschka A, Flowers ME, Cowen EW, Tkaczyk E, Farhadfar N, Jain S, Steven P, Luo ZK, Ogawa Y, Stern M, Yanik GA, Cuvelier GDE, Cheng GS, Holtan SG, Schultz KR, Martin PJ, Lee SJ, Pavletic SZ, Wolff D, Paczesny S, Blazar BR, Sarantopoulos S, Socie G, Greinix H, Cutler C
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501738
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.
Transplant Cell Ther 2021; 27(8): 632-641; Impact Factor=n.a.; Impact Factor 2020=n.a.; Typ=Journal Article;Research Support, N.I.H., Extramural;Research Support, N.I.H., Intramural;
Pidala J, Kitko C, Lee SJ, Carpenter P, Cuvelier GDE, Holtan S, Flowers ME, Cutler C, Jagasia M, Gooley T, Palmer J, Randolph T, Levine JE, Ayuk F, Dignan F, Schoemans H, Tkaczyk E, Farhadfar N, Lawitschka A, Schultz KR, Martin PJ, Sarantopoulos S, Inamoto Y, Socie G, Wolff D, Blazar B, Greinix H, Paczesny S, Pavletic S, Hill G
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 487015
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.
Transplant Cell Ther 2021; 27(10): 817-835; Impact Factor=n.a.; Impact Factor 2020=n.a.;
Typ=Consensus Development Conference, NIH;Journal Article;Research Support, N.I.H., Intramural; Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein RK, Cowen EW, Cheng GS, Sheshadri A, Bergeron A, Williams KM, Todd JL, Teshima T, Cuvelier GDE, Holler E, McCurdy SR, Jenq RR, Hanash AM, Jacobsohn D, Santomasso BD, Jain S, Ogawa Y, Steven P, Luo ZK, Dietrich-Ntoukas T, Saban D, Bilic E, Penack O, Griffith LM, Cowden M, Martin PJ, Greinix HT, Sarantopoulos S, Socie G, Blazar BR, Pidala J, Kitko CL, Couriel DR, Cutler C, Schultz KR, Pavletic SZ, Lee SJ, Paczesny S
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 497915
Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysis.
Vaccine 2021; 39(33): 4742-4750; Impact Factor=n.a.; Impact Factor 2020=3.641; Typ=Journal Article;Research Support, Non-U.S. Gov't;
Sattler C, Hoffmann P, Herzberg PY, Weber D, Holler B, Fehn U, Plentz A, Beckhove P, Winkler J, Edinger M, Herr W, Holler E, Wolff D
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 501740
Correction to: Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD consortium.
Wien Klin Wochenschr 2021; 133(13-14): 729-730; Impact Factor=n.a.; Impact Factor 2020=1.704; Typ=Published Erratum;
Lawitschka A, Brunmair M, Bauer D, Zubarovskaya N, Felder-Puig R, Strahm B, Bader P, Strauss G, Albert M, von Luettichau I, Greinix H, Wolff D, Peters C
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

ID: 414793
Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium.
Wien Klin Wochenschr 2021; 133(1-2): 41-51; Impact Factor=n.a.; Impact Factor 2020=1.704;
Typ=Journal Article;
Lawitschka A, Brunmair M, Bauer D, Zubarovskaya N, Felder-Puig R, Strahm B, Bader P, Strauss G, Albert M, von Luettichau I, Greinix H, Wolff D, Peters C
Medline-ID vorhanden, Web of Science-ID (ISI-LOC) vorhanden

Lorenz J, Rothhammer-Hampl T, Zoubaa S, Bumes E, Pukrop T , Kölbl O, Corbacioglu S, Schmidt NO, Proescholdt M, Hau P, Riemenschneider MJ. A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapyprediction in neurooncology. In: Acta Neuropathol Commun. 2020;8(1).

Fante MA , Holler B , Weber D , Angstwurm K, Bergler T, Holler E , Edinger M , Herr W , Wertheimer T , Wolff D. Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis. Ann Hematol 2020;99(9):2181-2190.

Kattner AS , Holler E , Holler B , Klobuch S , Weber D , Martinovic D , Edinger M , Herr W , Wolff D. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Ann Hematol 2020;99(4):847-853.

Maertens J, Logan AC, Jang J, Long G, Tang JL, Hwang WYK, Koh LP, Chemaly R, Gerbitz A, Winkler J, Yeh SP, Hiemenz J, Christoph S, Lee DG, Wang PN, Holler E , Mielke S, Akard L, Yeo A, Ramachandra S, Smith K, Pertel P, Segal F. Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation. Antimicrob Agents Chemother 2020; 64(4).

Bleckmann A, Kirchner B, Nietert M, Peeck M, Balkenhol M, Egert D, Rohde TV, Beißbarth T, Pukrop T. Impact of pre-OP independence in patients with limited brain metastases on long-term survival. BMC Cancer 2020; 20(1).

Herrmann A , Mansfield E, Tzelepis F, Lynagh M, Hall A. Use of the supportive care framework to explore haematological cancer survivors' unmet needs: a qualitative study. BMC Health Serv Res 2020; 20(1).

Kaiser U , Vehling-Kaiser U, Kück F, Mechie NC, Hoffmann A, Kaiser F. Use of symptom-focused oncological cancer therapies in hospices: a retrospective analysis. BMC Palliat Care 2020; 19(1).

Reinert C, Gerken M, Rathberger K, Krueger K, Klinkhammer-Schalke M, Lindberg-Scharf P, Koelbl O, Proescholdt MA, Riemenschneider MJ, Pukrop T , Bumes E, Hutterer M, Hau P. Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregivers. BMC Psychol 2020; 8(1).

Srinagesh HK, Ozbek U, Kapoor U, Ayuk F, Aziz M, Ben-David K, Choe H, DeFilipp Z, Etra A, Grupp SA, Hartwell MJ, Hexner E, Hogan WJ, Karol AB, Kasikis S, Kitko CL, Kowalyk S, Major-Monfried H, Lin, JY, Mielke S, Merli P, Morales G, Ordemann R, Pulsipher MA, Qayed M, Reddy P, Reshef R, Roesler W, Sandhu KS, Schechter T, Shah J, Sigel K, Weber D , Wolf M, Wudhikarn K, Young R, Levine JE, Ferrara J. The MAGIC Algorithm Probability (MAP) Is a Validated Response Biomarker of Treatment for Acute Graft-Versus-Host Disease. Biol Blood Marrow Transplant 2020; 26(3): S51-S51.

Kreitner R, Munte CE, Singer K , Stetter KO, Horn G, Kremer W, Kalbitzer HR. Complete sequential assignment and secondary structure prediction of the cannulae forming protein CanA from the hyperthermophilic archaeon Pyrodictium abyssi. Biomol NMR Assign 2020; 14(1): 141-146.

Wolff D. A few steps on the long road toward biomarkers in GVHD. Blood 2020; 135(15): 1196-1197.

Mohty M, Holler E , Jagasia M, Jenq R, Malard F, Martin P, Socié G, Zeiser R. Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness. Blood 2020; 136(17): 1903-1906.

Markey KA, Schluter J, Gomes ALC, Littmann ER, Pickard AJ, Taylor BP, Giardina PA, Weber D , Dai A, Docampo MD, Armijo GK, Slingerland AE, Slingerland JB, Nichols KB, Brereton DG, Clurman AG, Ramos RJ, Rao A, Bush A, Bohannon L, Covington M, Lew MV, Rizzieri DA, Chao N, Maloy M, Cho C, Politikos I, Giralt S, Taur Y, Pamer EG, Holler E , Perales MA, Ponce DM, Devlin SM, Xavier J, Sung AD, Peled JU, Cross JR, van den Brink MRM. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD. Blood 2020;136(1):130-136.

Gergoudis SC, DeFilipp Z, Özbek U, Sandhu KS, Etra AM, Choe HK, Kitko CL, Ayuk F, Aziz M, Baez J,, Ben-David K, Bunworasate U, Gandhi I, Hexner EO, Hogan WJ, Holler E , Kasikis S, Kowalyk SM, Lin, JY, Merli P, Morales G, Nakamura R, Reshef R, Rösler W, Srinagesh H, Young R, Chen YB, Ferrara, JLM, Levine JE. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α -1-antitrypsin. Blood Adv 2020; 4(24): 6098-6105.

Inamoto Y, Lee SJ, Onstad LE, Flowers MED, Hamilton BK, Jagasia MH, Martin PJ, Pavletic SZ, Pidala JA, Pusic I, Vogelsang GB, Wolff D, Carpenter PA. Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia. Blood Adv 2020;4(1):40-46.

Foell J, Kleinschmidt K, Troeger A, Turowski P, Spachtholz R, Ahrens N, Brosig AM, Evert M, Schmidt R, Wolff D , Edinger M , Eyrich M, Handgretinger R, Ellinger S, Corbacioglu S. A Phase II Stratified Trial to Assess Haploidentical tdepleted Stem Cell Transplantation in Patients with Sickle Cell Disease with no Available Sibling Donor. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 440-440.

Meedt E , Weber D , Eiz-Vesper B, Maecker-Kolhoff B, Bonifacius A, Schwarz K, Lorenz M, Delecluse S, Delecluse HJ, Holler E , Herr W , Edinger M , Wolff D. Case Report: Chronic Active epstein-barr Virus Infection (CAEBV) Controlled by Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) and Transfusion of EBV-specific T-cells. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 273-274.

Wagner E, Teschner D, Wolschke C, Janson D, Schaefer-Eckart K, Gartner J, Mielke S, Schreder M, Kobbe G, Kondakci M, Hilgendorf I, von Lilienfeld-Toal M, Klein S, Heidenreich D, Kreil S, Verbeek M, Grass S, Ditschkowski M, Gromke T, Koch M, Lindemann M, Huenig T, Schmidt T, Rascle A, Guldan H, Barabas S, Deml L, Wagner R, Wolff D. Comparison of Immune Cell Response to Cytomegalovirus Proteins Versus Peptides using an IFNgamma Elispot Assay to Monitor cytomegalovirus-specific Immunity after Hematopoietic Stem Cell Transplantation. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 457-458.

Toenges R, Edinger M , Bug G, Lawitschka A, Greinix H, Halter J, Arends J, Ayuk F, Klein S, Middeke JM, Wagner-Drouet E, Hilgendorf I, Baumgartner A, Wolff D. Current Practice in Nutrition after Allogeneic Hematopoietic Stem Cell Transplantation in Austria, Germany and Switzerland. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 604-605.

Bittrich M, Vucinic V, Grube M , Hentrich M, de Wit M, Kunz C, Metzner B, Humpe A, Stoltefuss A, Rank A, Movassaghi K, Kiani A, Khandanpour C, Schmidt-Hieber M, Hartmann F, Kroeger N. First Interim Results of NIS Optimob - Nationwide Trial of Mobilization and Collection of Hematopoietic Stem and Progenitor Cells in Multiple Myeloma and Lymphoma Patients. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 691-692.

Lelas A, Langer R, Rittenschober M, Desnica L, Greinix H, Dickinson A, Inngjerdingen M, Lawitschka A, Vrhovac R, Pulanic D, Klein S, Middeke JM, Edinger M , Wolff D. Incidence of Chronic graft-versus-host Disease - Results from a Prospective Multicentre Analysis of 2 Cohorts. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 336-337.

Holler E , Weber D , Hahn J , Mittermaier C , Kreitmeier KG , Hiergeist A, Salzberger B, Wolff D , Gessner A, Herr W , Edinger M. Restrictive use of Intravenous Antibiotics in Allogeneic SCT Pts with Fever due to Cytokine Release Syndrome Allows Microbiota Protection without Increase of Infections and TRM. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 345-345.

Wagner E, Teschner D, Wolschke C, Janson D, Schafer-Eckart K, Gartner J, Mielke S, Schreder M, Kobbe G, Kondakci M, Hilgendorf I, von Lilienfeld-Toal M, Klein S, Heidenreich D, Kreil S, Verbeek M, Grass S, Ditschkowski M, Gromke T, Koch M, Lindemann M, Huenig T, Schmidt T, Rascle A, Guldan H,Barabas S, Deml L, Wagner R, Wolff D. Standardized Monitoring of cytomegalovirus-specific Cellular Immunity can Improve Risk Stratification of Recurrent Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 470-471.

Peric Z, Peczynski C, Polge E, Kroger N, Socie G, Finke J, Holler E , Blaise D, Helbig G, Niittyvuopio R, Potter V, Bunjes D, Benedek I, Penack O, Schoemans H, Koenecke C, Basak G. The Impact of Pre-Transplant Depression and Anxiety on the Outcome of Allogeneic Stem Cell Transplantation, a Study of the TCWP of the EBMT. Bone Marrow Transplant 2020;55 Suppl TEM CELL T(SUPPL 1):758-758.

Qayed M, Kapoor U, Gillespie S, McCracken C, Abusin G, Aguayo-Hiraldo P, Ayuk F, Aziz M, Choe H, Grupp S, Hexner E, Holler E , Kowalyk S, Major-Monfried H, Merli P, Morales G, Nakamura R, Ozbek U, Pulsipher M, Roesler W, Schechter T, Shah J, Srinagesh H, Woelfl M, Wudhikarn K, Young R, Ferrara J, Kitko C, Levine J. The Magic Biomarker Algorithm Predicts Outcomes for Children with Acute Graft Versus Host Disease. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 81-82.

Styczynski J, Tridello G, Knelange N, Xhaard A, Socie G, Passweg J, Mielke S, Taskinen M, Blijlevens N, Rodriguez MAB, Solano C, Nikolousis E, Biffi A, Groll A, Junghanss C, Tsirigotis P, Lioure B, Jindra P, Holler E , Galaverna F, Fagioli F, de la Camara R, Mikulska M, Ljungman P. Use of Letermovir in Off-Label Indications: Infectious Diseases Working Party EBMT Retrospective Study. Bone Marrow Transplant 2020;55 Suppl TEM CELL T(SUPPL 1):113-114.

Styczynski J, Tridello G, Xhaard A, Medinger M, Mielke S, Taskinen M, Blijlevens N, Rodriguez MAB,Solano C, Nikolousis E, Biffi A, Groll AH, Junghanss C, Tsirigotis P, Lioure B, Jindra P, Holler E , Galaverna F, Fagioli F, Knelange N, Wendel L, Gil L, de la Camara R, Mikulska M, Ljungman P. Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study. Bone Marrow Transplant 2020.

Schuler E, Wagner-Drouet EM, Ajib S, Bug G, Crysandt M, Dressler S, Hausmann A, Heidenreich D, Hirschbuehl K, Hoepting M , Jost E, Kaivers J, Klein S, Kordelas L, Kriege O, Mueller L, Rautenberg C, Schaffrath J, Schmid C, Wolff D , Haas R, Bornhaeuser M, Schroeder T, Kobbe G. Venetoclax, Hypomethylating Agents and Dli for Salvage Treatment of Myeloid Malignancies Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation. Bone Marrow Transplant 2020; 55 Suppl TEM CELL T(SUPPL 1): 590-591.

McLornan DP, Malpassuti V, Lippinkhof-Kozijn A, Potter V, Beelen D, Bunjes D, Sengeloev H, Radujkovic A, Passweg J, Chalandon Y, Kröger N, Wulf GG, Johansson JE, Ciceri F, Bornhäuser M, Holler E, Guffroy B, Martin S, Neubauer A, Gramatski M, Robin M, Iacobelli S, Hayden P, Hernández, Boluda JC, Czerw T, Yakoub-Agha I. Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT. Br J Haematol 2020; 190(3): 437-441.

Gran C, Wang J, Nahi H, Koster L, Gahrton G, Einsele H, Niittyvoupio R, Edinger M , Beelen D, Ciceri F, Bornhäuser M, Finke J, de Wreede LC, Ljungman P, Mielke S, Tischer J, Garderet L, Schönland S, Yakoub-Agha I, Kröger N. Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT. Br J Haematol 2020; 189(5): e213-e217.

Beckhove P , Edinger M , Feuerer M, Gattinoni L, Abken H. International Regensburg Center for Interventional Immunology (RCI) symposium on "Synthetic immunology and environment-adapted redirection of T cells", 17-18 July, 2019, Regensburg, Germany. Cancer Immunol Immunother 2020; 69(4): 677-682.

Volpin V, Michels T, Sorrentino A, Menevse AN, Knoll G, Ditz M, Milenkovic VM, Chen CY, Rathinasamy A, Griewank K, Boutros M, Haferkamp S, Berneburg M, Wetzel CH, Seckinger A, Hose D, Goldschmidt H, Ehrenschwender M, Witzens-Harig M, Szoor A, Vereb G, Khandelwal N, Beckhove P. CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment. Cancer Immunol Res 2020; 8(9): 1163-1179.

Michels T, Bissinger S, Sennhenn P, Loferer H, Freire CM, Reidell O, Meier-Ewert S, Papadimitriou A, Beckhove P , Khandelwal N. A first-in-class SIK3 inhibitor, OMX-0370, effectively inhibits tumor growth in syngeneic tumor models, as single agent, by abolishing tumor resistance to immune-derived TNF. Cancer Res 2020; 80 Suppl S(16).

Gutzmer R, Vordermark D, Hassel JC, Krex D, Wendl C, Schadendorf D, Sickmann T, Rieken S, Pukrop T , Höller C, Eigentler TK, Meier F. Melanoma brain metastases - Interdisciplinary management recommendations 2020. Cancer Treat Rev 2020; 89.

Safi S, Yamauchi Y, Hoffmann H, Weichert W, Jost PJ, Winter H, Muley T, Beckhove P. Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer. Cancers (Basel) 2020;12(12).

Ammer LM, Vollmann-Zwerenz A, Ruf V, Wetzel CH, Riemenschneider MJ, Albert NL, Beckhove P , Hau P. The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma. Cancers (Basel) 2020; 12(10).

Schulz D, Streller M, Piendl G, Brockhoff G, Reichert TE, Menevse AN, Beckhove P , Hautmann MG, Bauer RJ, Ettl T. Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma. Carcinogenesis 2020; 41(7):984-992.

Klobuch S , Hammon K , Vatter-Leising S , Neidlinger E, Zwerger M, Wandel A, Neuber LM, Heilmeier B, Fichtner R , Mirbeth C , Herr W , Thomas S. HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation. Cells 2020; 9(5).

Jung EM, Wertheimer T , Putz FJ, Jung F, Kammerer S, Pregler B, Luerken L, Stroszczynski C, Beyer L. Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia. Clin Hemorheol Microcirc 2020; 76(2): 143-153.

Peschel G, Jung EM, Fisser C, Putz FJ, Wertheimer T , Sinner B, Lunz D, Jung F, Müller M. Interstitial lung opacities in patients with severe COVID-19 pneumonia by bedside high-resolution ultrasound in association to CO2 retention. Clin Hemorheol Microcirc 2020.

Hart C , Heudobler D , Linnemann B. [Thromboprophylaxis in ambulatory patients with cancer]. Dtsch Med Wochenschr 2020; 145(3): 130-134.

Lüke F , Orsó E, Kirsten J, Poeck H , Grube M , Wolff D , Burkhardt R, Lunz D, Lubnow M, Schmidt B,Hitzenbichler F, Hanses F, Salzberger B, Evert M, Herr W , Brochhausen C, Pukrop T , Reichle A , Heudobler D. Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells. EJHaem. 2020.

Fiedler M, Schulz D, Piendl G, Brockhoff G, Eichberger J, Menevse AN, Beckhove P , Hautmann M, Reichert TE, Ettl T, Bauer RJ. Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines. Exp Cell Res 2020; 396(1).

Crossland RE, Perutelli F, Bogunia-Kubik K, Mooney N, Milutin Gašperov N, Pučić-Baković M, Greinix H, Weber D , Holler E , Pulanić D, Wolff D , Dickinson AM, Inngjerdingen M, Grce M. Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease. Front Immunol 2020; 11.

Oberbauer R, Edinger M , Berlakovich G, Kalhs P, Worel N, Heinze G, Wolzt M, Lion T, Wekerle T. A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001). Front Med (Lausanne) 2020; 7.

Reichle A , Heudobler D , Gerner C, Pantziarka P, Martinelli E, Holler E , Corsi F, Ghibelli L. Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis). Front Oncol 2020; 10.

Kattner AS , Holler E , Herr W , Reichle A , Wolff D , Heudobler D. Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy. Front Oncol 2020; 10.

Harrer DC , Menhart K, Mayer S , Herr W , Reichle A , Vogelhuber M. Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report. Front Oncol 2020; 10.

Wolff D , Bardak J, Edinger M , Klinger-Schindler U, Holler E , Lawitschka A, Schoemans H, Herr W , Kröger N, Ayuk Ayuketang F. Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation-An Analysis of 2 German Transplantation Centers. Front Public Health 2020; 8.

Rasim K, Suttner S, Vogelhuber M , Herr W , Gessner A, Seelbach-Goebel B, Reuschel E. Epstein-Barr virus (EBV)-associated Burkitt-Lymphoma in Pregnancy. Geburtsh Frauenheilk 2020; 80(10): E272-E273.

Engelhardt M, Shoumariyeh K, Rösner A, Ihorst G, Biavasco F, Meckel K, von Metzler I, Theurich S, Hebart H, Grube M , Kull M, Bassermann F, Schäfer-Eckart K, Hoferer A, Einsele H, Rasche L, Wäsch R. Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany. Haematologica 2020.

Linnemann B, Seelbach-Goebel B, Heimerl S, Hart C. How Do We Treat Pregnancy-Related Venous Thromboembolism? Hamostaseologie 2020;40(1):54-63.

Hart C , Bauersachs R, Scholz U, Zotz R, Bergmann F, Rott H, Linnemann B. Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH). Hamostaseologie 2020; 40(5): 572-590.

Delacher M, Imbusch CD, Hotz-Wagenblatt A, Mallm JP, Bauer K, Simon M, Riegel D, Rendeiro AF, Bittner S, Sanderink L, Pant A, Schmidleithner L, Braband KL, Echtenachter B, Fischer A , Giunchiglia V, Hoffmann P , Edinger M , Bock C, Rehli M , Brors B, Schmidl C, Feuerer M. Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF. Immunity 2020; 52(2): 295-312.e11.

Siska PJ , Singer K , Evert K, Renner K , Kreutz M. The immunological Warburg effect: Can a metabolic-tumor-stroma score (MeTS) guide cancer immunotherapy? Immunol Rev 2020; 295(1):187-202.

Blazquez R , Rietkötter E, Wenske B, Wlochowitz D, Sparrer D , Vollmer E , Müller G , Seegerer J, Sun X, Dettmer K, Barrantes-Freer A, Stange L, Utpatel K, Bleckmann A, Treiber H, Bohnenberger H, Lenz C, Schulz M, Reimelt C, Hackl C, Grade M, Büyüktas D, Siam L, Balkenhol M, Stadelmann C, Kube D, Krahn MP, Proescholdt MA, Riemenschneider MJ, Evert M, Oefner PJ, Klein CA, Hanisch UK, Binder C, Pukrop T. LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer. Int J Cancer 2020; 146(11): 3170-3183.

van de Ven A, Mader I, Wolff D , Goldacker S, Fuhrer H, Rauer S, Grimbacher B, Warnatz K. Structural Noninfectious Manifestations of the Central Nervous System in Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract 2020; 8(3): 1047-1062.e6.

Shumilov E, Vehling-Kaiser U, Damnali G, Schulz X, Kaiser U , Bacher U, Kaiser F. Oral and Subcutaneous Anticancer Therapy Training Course for Non-physician Healthcare Professionals: a Survey Evaluating the Relevance of its Content and its Implications in the Practice of Cancer Care. J Cancer Educ 2020.

Herhaus P, Lipkova J, Lammer F, Yakushev I, Vag T, Slotta-Huspenina J, Habringer S, Lapa C, Pukrop T , Hellwig D, Wiestler B, Buck AK, Deckert M, Wester HJ, Bassermann F, Schwaiger M, Weber WA, Menze B, Keller U. CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma. J Nucl Med 2020; 61(12): 1765-1771.

Beckermann KE, Hongo R, Ye X, Young K, Carbonell K, Healey DCC, Siska PJ , Barone S, Roe CE, Smith CC, Vincent BG, Mason FM, Irish JM, Rathmell WK, Rathmell JC. CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation. JCI Insight 2020; 5(16).

Sawitzki B, Harden PN, Reinke P, Moreau A, Hutchinson JA, Game DS, Tang Q, Guinan EC, Battaglia M, Burlingham WJ, Roberts ISD, Streitz M, Josien R, Böger CA, Scottà C, Markmann JF, Hester JL, Juerchott K, Braudeau C, James B, Contreras-Ruiz L, van der Net JB, Bergler T, Caldara R, Petchey W, Edinger M , Dupas N, Kapinsky M, Mutzbauer I, Otto NM, Öllinger R, Hernandez-Fuentes MP, Issa F, Ahrens N, Meyenberg C, Karitzky S, Kunzendorf U, Knechtle SJ, Grinyó J, Morris PJ, Brent L, Bushell A, Turka LA, Bluestone JA, Lechler RI, Schlitt HJ, Cuturi MC, Schlickeiser S, Friend PJ, Miloud T, Scheffold A, Secchi A, Crisalli K, Kang SM, Hilton R, Banas B, Blancho G, Volk HD, Lombardi G, Wood KJ, Geissler EK. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials. Lancet 2020; 395(10237): 1627-1639.

Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F, Ciceri F, Cornelissen J, Malladi R, Duarte RF, Giebel S, Greinix H, Holler E, Lawitschka A, Mielke S, Mohty M, Arat M, Nagler A, Passweg J, Schoemans H, Socié G, Solano C, Vrhovac R, Zeiser R, Kröger N, Basak GW.Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol 2020; 7(2): e157-e167.

Beelen DW, Trenschel R, Stelljes M, Groth C, Masszi T, Reményi P, Wagner-Drouet EM, Hauptrock B, Dreger P, Luft T, Bethge W, Vogel W, Ciceri F, Peccatori J, Stölzel F, Schetelig J, Junghanß C, Grosse-Thie C, Michallet M, Labussiere-Wallet H, Schaefer-Eckart K, Dressler S, Grigoleit GU, Mielke S, Scheid C, Holtick U, Patriarca F, Medeot M, Rambaldi A, Micò MC, Niederwieser D, Franke GN, Hilgendorf I, Winkelmann NR, Russo D, Socié G, Peffault de Latour R, Holler E , Wolff D , Glass B, Casper J, Wulf G, Menzel H, Basara N, Bieniaszewska M, Stuhler G, Verbeek M, Grass S, Iori AP, Finke J, Benedetti F, Pichlmeier U, Hemmelmann C, Tribanek M, Klein A, Mylius HA, Baumgart J, Dzierzak-Mietla M, Markiewicz M. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MCFludT.14/L): a randomised, non-inferiority, phase 3 trial. Lancet Haematol 2020; 7(1): e28-e39.

Gökbuget N, Zugmaier G, Dombret H, Stein A, Bonifacio M, Graux C, Faul C, Brüggemann M, Taylor K, Mergen N, Reichle A , Horst HA, Havelange V, Topp MS, Bargou RC. Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia. Leuk Lymphoma 2020; 61(11): 2665-2673.

Weissinger EM, Metzger J, Schleuning M, Schmid C, Messinger D, Beutel G, Wagner-Drouet EM, Schetelig J, Baurmann H, Rank A, Stolzl F, Schäfer-Eckart K, Westphal K, Bethge W, von Harsdorf S, Bunjes DW, Heidenreich D, Klein S, Holler E , Kreipe HH, Jonigk D, Türüchanow I, Raad J, Papkalla A, von der Leyen H, Hambach L, Hamwi I, Ehrlich S, Krauter J, Stadler M, Ganser A. A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graftversus- host disease therapy. Leukemia 2020.

Staiger AM, Altenbuchinger M, Ziepert M, Kohler C, Horn H, Huttner M, Hüttl KS, Glehr G, Klapper W, Szczepanowski M, Richter J, Stein H, Feller AC, Möller P, Hansmann ML, Poeschel V, Held G, Loeffler M, Schmitz N, Trümper L, Pukrop T , Rosenwald A, Ott G, Spang R, Emed Demonstrator Project , German High Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL). A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL. Leukemia 2020;34(2): 543-552.

Riegel C , Boeld TJ , Doser K , Huber E, Hoffmann P , Edinger M. Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells. Leukemia 2020; 34(3): 895-908.

Sun X, Berger RS, Heinrich P, Marchiq I, Pouyssegur J, Renner K , Oefner PJ, Dettmer K. Optimized Protocol for the In Situ Derivatization of Glutathione with N-Ethylmaleimide in Cultured Cells and the Simultaneous Determination of Glutathione/Glutathione Disulfide Ratio by HPLC-UV-QTOF-MS. Metabolites 2020;10(7).

Strobl CD, Schaffer S, Haug T, Völkl S, Peter K, Singer K, Böttcher M, Mougiakakos D, Mackensen A, Aigner M. Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA. Mol Cancer Ther 2020;19(2):409-419.

Arlt A, von Bonin F, Rehberg T, Perez-Rubio P, Engelmann JC, Limm K, Reinke S, Dullin C, Sun X, Specht R, Maulhardt M, Linke F, Bunt G, Klapper W, Vockerodt M, Wilting J, Pukrop T , Dettmer K, Gronwald W, Oefner PJ, Spang R, Kube D. High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination. Mol Oncol 2020; 14(3): 571-589.

Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D , Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E , Xavier JB, Pamer EG, van den Brink MRM. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 2020; 382(9): 822-834.

Minderjahn J , Schmidt A, Fuchs A, Schill R, Raithel J , Babina M, Schmidl C, Gebhard C , Schmidhofer S , Mendes K , Ratermann A , Glatz D , Nützel M , Edinger M , Hoffmann P , Spang R, Längst G, Imhof A, Rehli M. Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1. Nat Commun 2020; 11(1).

Teufel A, Evert K, Ltzel T, Evert M, Koch C, Vogelhuber M, Schulte N, Demir H, Herr W , Gaiser T, Waidmann O, Ebert M. Differential Gene Expression May Predict Response to Somatostatin Analogues (SSAs) in Gastrointestinal (GI) Neuroendocrine Tumors (NETs). Neuroendocrinology 2020;110:21.

Gaerditz S , Mayer S , Grube M , Hahn J , Authier D , Marquardt K, Herr W. Acral necrosis as an unusual end-organ damage in multiple myeloma. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 105-105.

Harrer DC , Jakob M, Vogelhuber M , Lueke F , Rehe K, Corbacioglu S, Herr W , Reichle A , Heudobler D. Biomodulatory therapy induces long-lasting remissions in chemorefractory multi-system Langerhans cell histiocytosis. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 183-183.

Lueke F , Harrer DC , Menhart K, Wolff D , Holler E , Hellwig D, Herr W , Grube M , Vogelhuber M , Reichle A , Heudobler D. Biomodulatory treatment regimen, MEPED, rescues relapsed and refractory classic Hodgkin's disease. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4):90-90.

Lueke F , Harrer DC , Hahn J , Grube M , Pukrop T , Herr W , Reichle A , Heudobler D. Continuous complete remission in two patients with acute lymphoblastic leukemia and severe fungal infection following dose-reduced chemotherapy. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 35-35.

Luke F , Orso E, Kirsten J, Poeck H , Grube M , Wolff D , Burkhardt R, Lunz D, Lubnow M, Schmidt B, Hitzenbichler F, Hanses F, Salzberger B, Evert M, Herr W , Brochhausen C, Pukrop T , Reichle A , Heudobler D. Coronavirus disease 2019 is associated with multi-lineage, morphologic changes in peripheral blood cells. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 202-202.

Sterz U , Grube M , Herr W , Menhart K, Vogelhuber M. Dual checkpoint inhibition in advanced metastatic osteosarcoma leads to remission of all tumor manifestations a case report of a stunning success in a 37 year-old patient. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 229-229.

Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, Middeke JM, Kroeger N, Ayuketang FA, Eder M, Bethge W, Finke J, Bertz H, Kobbe G, Kaufmann M, Platzbecker U, Beverungen D, Schmid C, von Bonin M, Heberling L, Teipel R, Bug G, Fraccaroli A, Tischer J, Holler B , Wolff D , Luft T, Roesler W, Schaefer-Eckart K, Dressler S, Scheid C, Holtick U, Klein S, Blau IW, Burchert A, Wulf G, Hasenkamp J, Kaun S, Wittke C, Wortmann F, Bornhaeuser M, Schetelig J, German Registry Stem Cell German Cooperative Transplant Grp. Evaluation of pregnancies after allogeneic stem cell transplantation during the last 15years in Germany. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 240-240.

Flamann C, Zeun J, Kremer A, Voelkl S, Peter K , Kreutz M , Buettner-Herold M, Kellner C, Saul D, Mougiakakos D, Mackensen A, Bruns H. Immune cell regulation by vitamin D-3 during allogeneic hematopoietic stem cell transplantation (HSCT). Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 54-54.

Peeck M, Pukrop T , Rohde V, Beissbarth T, Nietert M, Kirchner B, Bleckmann A. Impact on Long-Term Survival of Pre-OP Frailty of Patients with Limited Brain Metastases. Oncology Research and Treatment 2020; 43 Suppl 1(): 212-212.

Meedt E , Held G, Poeschel V, Loher A, Luerken L, Menhart K, Hellwig D, Grube M , Herr W , Mayer S. Inflammatory aortitis in a patient with aggressive B-cell lymphoma during treatment within the NIVEAU trial: Gradual re-exposition with Nivolumab, Rituximab, Gemcitabine and Oxaliplatin identifies G-CSF as the provoking agent. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 67-68.

Kroeger N, Bittrich M, Vucinic V, Grube M , Hentrich M, de Wit M, Kunz C, Metzner B, Humpe A. Non-Interventional Optimob-Study: a Nationwide Evaluation of Mobilization and Collection ofHematopoietic Stem and Progenitor Cells in Patients with Multiple Myeloma (MM) and Lymphoma inClinical Practice. Oncology Research and Treatment 2020; 43 Suppl 1(): 131-131.

Sattler C , Hoffmann P , Weber D , Holler B , Fehn U , Plentz A, Beckhove P , Winkler J, Edinger M , Herr W , Holler E , Wolff D. Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - a single center retrospective efficacy analysis. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 50-50.

Stritzke F, Joachim L, Bek S, Nedelko T, Bassermann F, Heidegger S, Poeck H. Tumor-intrinsic RIG-I signaling modulates immunogenicity of tumor cell-derived extracellular vesicles that can mediate T cell-based antitumor immunity. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 193-193.

Orberg ET, Goettert S, Pianka A, Heidegger S, Poeck H. Type-I interferon-inducing microbial-derived metabolites promote resistance to gastrointestinal damage after chemotherapy and irradiation and protect from graft-versus-host disease. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 54-54.

Kaiser U , Vehling-Kaiser U, Kalteis M, Kaiser F. Using rain ponchos against viruses - Specialised outpatient palliative care (SAPV) during the Covid-19 pandemic. Oncology Research and Treatment 2020; 43 Suppl 4(SUPPL 4): 211-212.

Utpatel K, Calvisi DF, Köhler G, Kühnel T, Niesel A, Verloh N, Vogelhuber M , Neu R, Hosten N, Schildhaus HU, Dietmaier W, Evert M. Complexity of PEComas : Diagnostic approach, molecular background, clinical management. Pathologe 2020;41(Suppl 1):9-19.

Uhl FM, Chen S, O'Sullivan D, Edwards-Hicks J, Richter G, Haring E, Andrieux G, Halbach S, Apostolova P, Büscher J, Duquesne S, Melchinger W, Sauer B, Shoumariyeh K, Schmitt-Graeff A, Kreutz M , Lübbert M, Duyster J, Brummer T, Boerries M, Madl T, Blazar BR, Groß O, Pearce EL, Zeiser R. Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans. Sci Transl Med 2020; 12(567).

Blazquez R , Sparrer D , Wendl C, Evert M, Riemenschneider MJ, Krahn MP, Erez N, Proescholdt M, Pukrop T. The macro-metastasis/organ parenchyma interface (MMPI) - A hitherto unnoticed area. Semin Cancer Biol 2020; 60(): 324-333.

Pamler I, Richter E, Hutchinson JA, Hähnel V, Holler E , Gessner A, Burkhardt R, Ahrens N. Bacterial contamination rates in extracorporeal photopheresis. Transfusion 2020; 60(6):1260-1266.

Schatlo B, Stockhammer F, Barrantes-Freer A, Bleckmann A, Siam L, Pukrop T , Rohde V. 5-Aminolevulinic Acid Fluorescence Indicates Perilesional Brain Infiltration in Brain Metastases. World Neurosurg X 2020;5.

Kaiser F, Schulz X, Hoffmann A, Kaiser F, Vehling-Kaiser U, Kaiser U. [A survey among family doctors on care reality of patients under oral tyrosine kinase inhibitor therapies]. Z Evid Fortbild Qual Gesundhwes 2020; 158-159(): 30-38.

Munker S, Vogelhuber M , Bornschein J, Stroszczynski C, Evert M, Schlitt H, Herr W , Teufel A. EpiCO (epirubicin, cyclophosphamide and vincristine) as treatment for extrapulmonary high-grade neuroendocrine neoplasms. Z Gastroenterol 2020; 58(2): 133-136.